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INTRODUCTION 
The word Pharmacognosy is derived from the  Greek words, pharmakon 
(drug) and gnosis (knowledge). The term Pharmacognosy was used by the Austrian 
physician Schmidt in 1811 and in 1815 by C.A.Seydler in a work titled “Anelecta 
Pharmacognostica”. Pharmacognosy is the study of natural product molecules 
(typically secondary metabolites) that are useful for medicinal, ecological, gustatory 
or other functional properties.[1] 
The contemporary study of  Pharmacognosy can be divided into the fields of 
1. Medical ethnobotany 
The study of the traditional use of plants for medicinal purposes. 
2. Phytotherapy 
The study of medicinal uses of plant extract. 
3. Phytochemistry 
The study of chemicals and the identification of new drug derived from plant 
sources. 
 4. Zoo pharmacognosy 
The study of animals self medicate, by selecting and using plants, soils and 
insects to treat and prevent diseases.   
5. Marine pharmacognosy 
The study of chemicals derived from marine organisms 
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ANTITHYROID ACTIVITY [2] 
Thyroid gland                    
  The thyroid is a butterfly shaped endocrine gland located in the lower front of 
neck. The thyroid gland secretes thyroid hormones and carried to every tissue in the 
body .Thyroid hormones help the body use energy stay warm and other organs as they 
work normally. 
Hyperthyroidism 
                      The term hyperthyroidism refers to any condition in which there is too 
much of thyroid hormone produced in the body. In other words, the thyroid gland is 
overactive. The thyroid gland secretes excessive thyroid hormones triiodothyroxine 
(T3) and tetraiodothyroxine (T4). 
                      Hyperthyroidism is a type of thyrotoxicosis ,a hyper metabolic clinical 
syndrome. Graves disease is another type of hyperthyroidism. Thyroid hormone is 
important to a cellular level, affecting nearly every type of tissue in the body. The 
thyroid makes the right amount of hormones T3 and T4 in healthy people. Shortly, the 
thyroid runs our metabolism. 
Causes [3] 
1. Getting too much of iodine  
2. Graves disease 
3. Inflammation of the thyroid because of viral infections. 
4. Non cancerous growth of thyroid gland. 
5. Some tumors of testes or ovaries. 
6. Taking large amounts of thyroid hormone. 
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Symptoms    
 Difficulty in concentration 
 Fatigue 
 Frequent bowel movements  
 Enlarged thyroid gland(GOITER) 
 Intolerance of heat 
 Increased appetite   
 Increased sweating 
 Irregular  menstruation in women 
 Nervousness 
 Restlessness 
 Weight loss (rarely weight gain) 
 Breast development in men 
 Clammy skin 
 Diarrhoea 
 Loss of hair  
 Tremor in hands 
 High blood pressure 
 Itching 
 Protruding of eyes 
 Irregular heart beats 
 Difficulty in sleeping 
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Diagnosis 
 Diagnosis of hyperthyroidism is confirmed by laboratory tests 
1. To measure the amount of thyroid hormones T3 andT4 
2. Measure TSH in the blood 
3. Thyroid scan will find out the over activeness or goiter or 
inflammation. 
4. A thyroid uptake is the test to measure the ability of the gland to 
collect iodine. 
Treatment[4] 
Antithyroid medications 
Antithyroid drugs 
          Drugs used for antithyroid category are Methimazole and Propyl thiouracil 
(PTU) Methimazole is preferred due to less side effects and quick control of 
overactive thyroid and do not cause any damage to thyroid gland. PTU is used only in 
rare conditions. 
Beta blockers  
                      The beta adrenergic blocking agents block the action of thyroid 
hormone in our body, but it does not change the high levels of thyroid hormone in our 
blood. Propanolol was the first drug to be developed. Atenolol, Metoprolol, Nadolol 
and Inderal as  twice a day dosage. 
Radioactive iodine 
                         Radioactive iodine is most widely used for the permanent treatment of 
hyperthyroidism. Radioactive iodine damage or destroys the thyroid hormone. 
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When it is taken, the level of thyroid nodules shrink in size and the level of 
thyroid   hormone in blood returns to normal. 
Surgical  removal 
It is another permanent cure for hyperthyroidism. The important case is such 
that the patient has hyperthyroidism due to a hot nodule in the lower aspect of the may 
need to remove the entire lobe which contains the hot nodule .If the thyroid must be 
removed with surgery, the patient must take the thyroid hormone by pills for rest of 
the life. 
Natural products in modern medicine [6] 
A Natural product is a chemical compound or substance found in living 
organism in nature having pharmacological and biological activity. WHO reveals that 
study  about 80% of the world’s population still relies on traditional medicine. Natural 
products still play a very important role in the medicine in remain 20%of the world’s 
population. Between 1983 and 1994, the new approved drugs have natural products as 
their source as 41%. 
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The role of natural products in modern medicine 
 
 
 
 
Medicinal plants in modern medicine [7] 
 The widely held belief that modern medicines are all the product of complex 
obtained from higher plants, resulting in sales exceeding $12 billion annually in the 
United States alone, and about 25% of all prescriptions contain one or more active 
ingredients from plants. Indeed, pharmaceutical firms that once shunned natural-
products research are now beginning to study the possibilities of this resource. 
Around the world, numerous companies have been formed to explore the potential of 
plants as modern medicines. Many names could be cited of plants, long in use by 
indigenous peoples, that have found their way into modern medicine. 
Example: Pilocarpus jaborandi, a shrubby tree of northeastern Brazil that is 
the source of pilocarpine, a compound used to reduce the intraocular pressure 
resulting from glaucoma. In Brazilian folk medicine it was originally used to increase 
salivation and cause swelling. The leaves were introduced into Europe in 1873, and 
by 1877 the compound pilocarpine, isolated from the leaves, began to be employed in 
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ophthalmology. More recently the drug has also been approved, by the U.S. Food and 
Drug Administration, for the treatment of dry-mouth syndrome (a side effect of 
certain cancer treatments and a disease of aging).Recent domestication of Pilocarpus 
species as crop plants is taking the pressure off the wild sources.  
 Not all plant-derived drugs have backgrounds in traditional and folk medicine. 
Some of them have instead been developed as the result of a broad-scale, random 
search of the plant kingdom. One example is the discovery of taxol, which is derived 
from the bark of the Pacific yew, Taxus brevifolia. Recently introduced into the war 
on cancer, this drug is now used either alone or in combination with other therapies 
for the treatment of breast and ovarian cancer. Current Problems and Prospects as 
new screening systems are developed, even well-known plants are subjected to 
reanalysis in hopes of identifying new pharmacological actions. Even so, fewer than 
one percent of the world's known 265,000 species of higher plants have as yet been 
exhaustively examined for their chemical composition and medical potential. 
The pharmacological search of the balance of the plant kingdom is truly a race 
against time, as deforestation and species extinction, coupled with the loss of 
knowledge about the traditional medicinal uses of plants, are reducing this vast 
phytochemical reservoir with increasing speed.  
Clinical studies with plant extracts are being initiated, and the results with 
many species are encouraging. For example, the prickly pear cactus, Opuntiaficus-
indica, has been studied for use by patients with benign prostatic hypertrophy, a 
disease found in middle-aged and older men. Dried flowers of the species were given 
to patients, and results were so promising that further clinical trials are now under 
way. Many plants deserve evaluation for clinical application in modern medicine. 
Introduction	
 
	 	8	
 
This appears tobe a promising direction for future studies aimed at improving human 
health. 
Natural products in treating hyperthyroidism  
Thyroid hormones play an important role in development, metabolism, 
thermoregulation, and growth[8] . However, under several pathological conditions 
like Graves’ disease, tumors of thyroid and pituitary gland stimulate thyroid cells to 
produce more hormones, which results in a hyperthyroid state [9]. Alterations in the 
level of these hormones lead not only to altered basal metabolic rate but also to many 
health problems. Particularly, hyperthyroidism, if not treated properly, sometimes 
ends up with the common health problems such as diabetes mellitus and 
cardiovascular diseases.[10]  Resemble to the human hyperthyroidisms were easily 
achieved in rodents by continuous treatment of l-thyroxine (LT4), a synthetic form of 
thyroid hormone.[10,11]Hyperthyroidism leads to oxidative damage of liver [12], 
osteoporosis [13], heart failure[14]  and increased risk of heart attack [15] 
Herbal medicine derived from plant extracts are used for the treatment in wide 
variety of clinical diseases. Plants derived natural products such as flavonoids, 
terpenoids, steroids, coumarins, alkaloids etc have diverse pharmacological properties 
showing antioxidant and antithyroid activity.[16] 
Lemon balm 
It is approved by the German Commission for nervous sleeping disorders and 
gastrointestinal complaints. The free dried extractsof lemon balm show the 
antithyroid activity by binding to TSH and prevents subsequent thyroid hormone 
production and release. 
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Bugle weed 
Aqueous extract of bugle weed binds with TSH and TSH like 
immunoglobulin inhibits the enzymatic reaction that converts peripheral T3and T4. 
Grom well 
Cabbage turnips and rutabags, soybeans, peanuts, pine nuts millets interfere 
with thyroid iodine uptake. 
Motherwort 
It is traditional heart tonic and uterine stimulant. It is adjuvant for thyroid 
hyper function. 
Ayurveda 
                  Traditional study reveals that the fruit of amla for hyperthyroidism to 
reduce the T3 and T4 . 
Chinese medicine 
    Brown sea weed, Chinese yam (Dioscoreaoppositifolia), Fritillaria, 
Scrophularia and Rhemanniaglutinosa are traditionally given as combinations rather 
than single herbs .It is sold in the form of supplement. They are target for treatment  
of hyperthyroidism. 
Antioxidant activity [17] 
              Antioxidant is a molecule that inhibits the oxidation of other 
molecules.Antioxidant means the activity of numerous vitamins, minerals and other 
phytochemicals to protect the damage caused by reactive oxygen species 
.Antioxidants are widely used in dietary supplement and have been investigated for 
the prevention of diseases such as cancer, coronary heart disease and even altitude 
sickness. Although initial studies suggested that antioxidant supplements might 
Introduction	
 
	 	10	
 
promote health, later large clinical trials with a limited number of antioxidants 
detected no benefit and even suggested that excess supplementation with certain 
putative antioxidants may be harmful. Antioxidants also have many industrial uses, 
such as preservatives in food and cosmetics and to prevent the degradation of rubber 
and gasoline. 
Oxidative stress 
                 Oxidative stress is a modulation of thiol redox reactions, involved mainly 
in signalling pathways. Therefore, non-radical oxidants (enzymatically generated 
hydrogen peroxide, other peroxides, quinones, etc.) play a basic role in the oxidation 
of thiols for the sake of signalling, without the necessityof formation of free radical 
intermediates (Ghezziet al.,2005; Jones, 2006; 2008). As oxidative stress appears to 
be an important part of many human diseases, the use of antioxidants 
in Pharmacology is intensively studied, particularly as treatments for stroke 
and neurodegenerative diseases. Moreover, oxidative stress is both the cause and the 
consequence of diseases. 
Functions[17] 
The main function of antioxidant system is keep the oxidants at optimum level 
not to remove oxidants entirely. It defences system scavenges and minimizes the free 
radical formation. It is suggested for an inverse relationship between dietary intake of 
antioxidant rich food and incidence of human diseases. 
Natural product s having antioxidant activity[18] 
Plant based antioxidants are replaced  by synthetic ones for safety concerns. 
The plants have antioxidant properties which protect our cells from oxidative damage, 
which is further linked to many diseases. These antioxidant properties of plants are 
due to various phytochemicals  present in the plants. 
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Examples are 
Emblica officinalis 
Andrographi spaniculata 
 Curcuma domestica 
Trigonella foenum 
 Aloe vera 
Zingiber officinalis 
Moringa oleifera 
Anti hyper glycemic activity[19] 
Hyper glycemia occurs when the glucose level is higher than the usual level of 
our blood. 
Causes 
                People who are older, overweight, have family members with diabetes or 
form certain ethnic groups are also develops  hyperglycemia. 
Is hyper glycemia same as diabetes 
 Hyperglycemia is a symptom of diabetes .we can have hyperglycemia 
without diabetes. 
Synthetic drugs used for hyperglycemia[20,21,22,23,24] 
Insulin 
                Insulin injections are used to provide the necessary insulin for the body 
which needs but lacks in some cases. Rapid acting brands are Novolog,Apidra  and 
Humalog . Short  acting brands  Humulin R and NovalinR . 
Alpha glucosidase inhibitors 
             It slowdowns the breakdown of complex sugars to glucose in the 
intestine.Examples are Precose and Glycol. 
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Biguanides 
It reduces the amount of glucose produced by the liver and reduces the 
resistance to insulin in the cells. Metformin (Glucophage), Riomet, GlucophageXR 
Meglitinides 
It stimulates the pancreas to release insulin after meals Eg Starlix and Prandin. 
Thiazolidinediones 
It reduces insulin resistance, production of glucose by the liver and liver and 
glucose uptake by the muscles. Eg Rosiglitazone and Pioglitazone. 
Dpp-4 inhibitors 
It stimulates the insulin production and reduces glucose release in the liver. 
Sulphonyl ureas 
It stimulates the insulin production. Eg Chlorpropamide, Glyburide, Glipizide, 
Glimepride, Tolbutamide and Tolazamide. 
Natural products in treating hyperglycemia[25,26,27] 
The antihyperglycemic effect of the plants are for their ability to restore the 
functions of pancreatic tissues by increasing output or inhibit the intestinal absorption 
of glucose or to the facilitation of metabolites in insulin dependent processes. 
Examples; Allium sativum, Allium cepa, Coccinia indica, Ceasalpinia 
bonducella, Eugenia jambolana etc., 
Reason for selecting Artemisia nilagirica 
Recent studies of thyroid inhibiting compound of plant origin have yielded an 
impressive assay of novel structure. In my study, methanolic extract of Artemisia 
nilagirica is used. 
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Traditionally Artemisia nilagirica is used for the treatment of poor appetite, 
indigestion, constipation, irregular menstruation, epilepsy, typhoid, insomnia, gout, 
measles, cancer, antiseptic, antioxidant, anthelmentic, expectorant, diuretic, 
diaphoretic, cholagogue and insect repellant.[28] 
    In this study,  Artemisia nilagirica is evaluated for antithyroid, antioxidative, 
antihy perglycemic activity 
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AIM AND SCOPE OF THE STUDY 
 
In recent years, much effort has been applied to the synthesis of potential 
anthyroid, antihyperglycemic and antioxidative drug. However a vast amount of 
herbal drug has given relatively small improvements over the synthetic drug. There is 
a continued need for new templates to use in the design of potential drug. Natural 
products provide such templates. 
   Artemisia nilagirica is used in traditional medicine for the treatment of various  
ailments such as poor appetite, indigestion, constipation, travel sickness, parasitic 
infection, irregular menstruation, menstrual pain, cramp, cold, epilepsy,  typhoid, 
tuberculosis, urinary calculi and fever. The purpose is to link the traditional concepts 
and uses of herbal drugs, herbal products and certain phytochemicals for potential 
phytomedicine using modern scientific approaches. 
The phytochemical studies on the leaves have been reported the presence of 
coumarins, flavonoids, tannins, terpenoids, volatileoil, carbohydrates and sterols. The 
present research is focused to investigate the antithyroid, anti hyperglycemic and 
antioxidative effects of Artemisia nilagirica. 
  This work has been designed for the  following studies on the leaves of 
Artemisia nilagirica. 
 Pharmacognostical studies on the leaves 
 Preliminary phytochemical screening on the extracts of Artemisia nilagirica. 
 Estimation of total phenols, total tannins and total flavonoids. 
 Identification of the active principle in methanolic extract of A.nilagirica by 
TLC  
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 Isolation of active principle from methanolic extract of A.nilagirica using 
column chromatography. 
 Structural elucidation of the active principle by using                                   
analytical processes such as spectroscopy (UV, FTIR & NMR). 
 Quantification of the active principle in the methanolic extract of A.nilagirica 
by HPLC 
 Pharmacological activities 
Invitro antioxidants activity 
 DPPH radical scavenging activity 
 Hydrogen peroxide scavenging activity 
 Antioxidant activity using cod-liver oil 
1. In vivo antioxidant activities 
 Lipid peroxidation (LPO) 
 Super oxide dismutase (SOD) 
 Catalase activities (CAT) 
 Glutathione content (GSH) 
2.In vivo antithyroid activity  
 Estimation of T3 and T4 by Radioimmunoassay 
3.Invivo antihyperglycemic activity 
 Estimation of serum glucose concentration. 
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REVIEW OF LITERATURE 
 
Literature review refers to any collection of materials on a topic and a 
summary of sources. It provides with a handy guide to a particular topic. The 
literature review of Artemisia nilagirica and other varieties reveals that the following 
works have been already carried out on those plants. 
 
Artemisia nilagirica 
PHARMACOLOGICAL STUDIES 
1.Samaiya.G.C,.et al [1986] have proved the Antimicrobial efficiency of essential oil 
of the leaves of Artemisia nilagirica. The essential oil from the leaves of Artemisia 
nilagirica showed a strong zone of inhibition against Bacillus substilis, k. Pneumonia, 
S.faecalis, B.cereus and staphylococcus aureus[ 29] 
2..Shafid.D.M,et al.,[2004]have described the Composition and Antifungal activity 
of the oil of Artemisia nilagirica on the plant pathogens phytophtheracapsici [30] 
3.Verma.P.R et al.,[2007} have described the Larvicidal activity of Artemisia 
nilagirica (Clarke) pamp and Ocimum sanctum Linn a preliminary herb.[31] 
4.Chowdary.H et al.,[2003]have evaluated the Invitro Antifungal activity of two 
essential oils on Drechslerasorokiniana causing spot blotch of Wheat .[32] 
5.Suseela.V, et al [2009] have described  the Free radical scavenging potential of 
aqueous extract of Artemisia nilagirica (Clarke) pamp leaves.[33] 
6.Abdul R Ahmeethunisha , et al., [2010] have evaluated the Antibacterial activity 
of Artemisia nilagirica leaf extracts against Clinical and Phytopathogenic 
bacteria.[34] 
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7.Vijayalakshmi A et al.,[2011] have described about the Anticonvulsant activity of 
Artemisia nilagirica leaves .[35] 
8.Perumal.P  et al.,[2010] have studied the Antitumor and Antioxidant activity of 
Artemisia nilagirica  Ehrlich’s Ascites carcinoma in the Swiss Albino mice.[36] 
9.Devamurari.V.P., et al[2010] have proved the Anticancer activity of Artemisia 
nilagirica. [37] 
 
PHYTOCHEMICAL STUDIES 
1.Haider,F, et al.,[2007] have studied the Oil constituents of Artemisia nilgirica 
variety septentrionales during different growth phases at subtropical conditions of 
North Indian plain.[38] 
2.Devmurari V.P., et al [2010] have evaluated the  Antibacterial activity of Ethanolic 
Extract of Artemisia nilagirica.[39] 
PHARMACOGNOSTICAL STUDIES. 
1.N.Pavalarani,et al [2012] have studied  the Pharmacognostic and Phytochemical 
screening of Artemisia nilagirica leaves found in Nilagiris District of Tamilnadu.[40] 
OTHER VARIETIES. 
Artemisia vulgaris 
PHYTOCHEMICAL STUDIES 
1.Bagci.E,et al [2010]  have studied  the Essential oil  composition of the aerial parts 
of the two Artemisia species (A.vulgaris and A.absinthium) from East Antolian region  
[41] 
2.Lohani.H,et al.,[2007]  have described the chemical composition of Essential oil of 
Artemisia vulgaris from three different areas of Uttaranchal at two periods (June and 
November)[42] 
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3.Bagchi.G.D.et al[2004] have studied the effect of winter and summer seasons on 
essential oil quality  of Artemisia vulgaris grown in north Indian plains.[43] 
4.Thao.N.T.P et al [2004]  have described the Artemisia vulgaris L.from Vietnam 
;the chemical variability and composition of the oil along the vegetative life of the 
plant.[44] 
5.Carnat.A.et al[2000]  have  isolated two Major dicaffeoylquinic acids fromthe 
flowering tops of Artemisia vulgaris.[45] 
6.Natmuller.R. et al [1981] have described about the New irregular monoterpenes in 
the oil of Artemisia vulgaris.[46] 
7.Ikhsanova.M.A.et al[1986] have described about the Coumarins like (esculin, 
esculetin, umbelliferone and scopoletin) from Artemisia vulgaris.[47] 
STRUCTURE OF SCOPOLETIN[ 48] 
 
7-hydroxy-6-methoxychromen-2-one or 7-Hydroxy-5-methoxycoumarin [20] 
PHARMACOLOGICAL STUDIES 
1.Villasenor.I.M,Landrid [2006] have compared the  anti hyperglycaemic potentials 
of medicinal plants  like Artemisia vulgaris, Solanumnigrum etc.,[48] 
2.Gilani A.H.et al[2005]  have described the Hepatoprotective activity of aqueous-
methanol extract of the aerial parts of  Artemisia vulgaris.[49] 
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PHARMACOGNOSTICAL STUDIES 
Artemisia nilagirica (C.B.Clarke) is an aromatic plant belonging to the family 
Compositae 
Synonym [50] 
Artemisia vulgaris L.variety nilagirica C.B.Clarke 
Common Name [51] 
Titapati 
Systematic position [51] 
Kingdom                   - Plantae 
Subkingdom              - Angiosperms 
Division                     - Magiliophyta 
Class                          - Rosopsida 
Order                         - Asterales 
Genus                        - Artemisia 
Species                      - nilagirica 
Vernacular names [52] 
English               - Indian wormwood 
Hindi                  - Dona, Majpatri, Nagdona 
Kannada             - Majepatri 
Malayalam         - Masipatri, Makkippuvu     
Sanskrit              - Nagadaman 
Tamil                 - Masipathri, Makkipoo 
Telugu                - Machipathri, Davanamu 
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Geographical distribution [53] 
It is found in Asia, Europe, Northern Africa, Alaska and North America 
Habit and Habitat of the plant [54] 
 Indian wormwood is an aromatic shrub, 1-2m high, yellow or dark red small 
flowers, grows throughout India in hills up to 2400 elevation. This medicinal herb is 
erect, hairy, often half woody. It is a tall, aromatic, pubescent or villous shrub like 
herb found throughout hilly regions of India. 
Description of the plant [52] 
Leaves 
The leaves are simple leaves, arranged oppositely one another, lobed, laciniate 
or pinnatipartite and 5-4 long. 
Stem 
Red purplish angular grooved stem, paniculately branched and leafy. 
Flowers 
Flower heads are small, ovoid or globosely in panicle racemes. It is many petaled and 
pale yellow. 
Fruits 
The fruits are achenes. 
Seed 
Radicle is short. 
Root  
The root system is fibrous. 
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MACROSCOPICAL AND MICROSCOPICAL STUDY  
Materials and methods 
     Fresh leaf was used for microscopical examination .The cut portion of the leaf 
was first fixed using FAA (Formalin-5ml+ Acetic acid -5ml+70% ethanol-
90ml).After 24hrs of fixing ,the specimens were dehydrated  with graded series of 
tertiary butyl alcohol, then infiltration was carried by gradual addition of paraffin wax 
(melting point 58-600 C) Then the specimens were cast into paraffin blocks.The 
paraffin embedded specimens were sectioned  with the help of  Rotary microtome. 
The sections were stained with toluidine blue. 
Leaf 
The transverse section of the leaf exhibits thick and prominent midrib and thin 
lamina (fig1). 
Midrib 
 The midrib consists of thick and wide adaxial conical hump & wide  and large 
abaxial midrib part. The epidermis of the midrib is very thin, darkly stared and the 
cells are not much distinct. There is a sub epidermal layer of small, elliptical, thin 
walled cells. The ground tissue is parenchymatous, the cells being polyhedral, thin 
walled, angular and compact. The midrib is 900µm thick, the adaxial hump is 450µm 
wide and the abaxial part is 1mm wide .The vascular system of the midrib consists of  
larger, semicircular main strand and 2 smaller accessory bundles located on the upper 
lateral part of the main bundle. The vascular bundles are collateral with long radial 
lines of wide, thick walled, angular xylem elements and a thick abaxial arc of phloem 
elements .(Fig2.1) 
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Lateral vein 
The lateral vein is flat on the adaxial side and broadly conical on the abaxial 
side . It is 320µm thick and 200µm wide. There is a single collateral vascular bundle 
which includes a few short, xylem strands and an arc of phloem elements on the 
abaxial side. The ground tissue including the epidermis is fairly larger, thin walled 
and compact. There is a small, collateral, vascular bundle situated in the middle of the 
lateral vein (Fig2.2) 
Lamina 
The lamina of the leaf is dorsiventral and bifacial with much dilated fairly 
thick walled adaxial epidermal cells which are 20µm thick .The outer tangential walls 
of the cells are slightly conical. The abaxial epidermal cells are very thin, cylindrical 
and thick walled. There is a single, row of cylindrical less compact palisade layer of 
cells and about 4 layers of spherical and lobed spongy parenchyma cells.(Fig 2.3) 
 
Petiole 
The distal part of the petiole has 2 prominent lateral wings and central thick 
and broad petiole proper. The lower part of the petiole is 3 lobed and the upper part is 
semi circular. The petiole is 800µm thick, the adaxial part is 500µm wide and abaxial 
lobed part is 750µm wide. The epidermis is very thin comprising small, squarish thick 
walled cells. The ground tissue is parenchymatous, thin walled polygonal and 
compact. There are 2 large, unequal, vascular bundles placed in the lower part of the 
petiole. The vascular bundles are collateral with dense, compact rows of small, xylem 
elements and thick band of compact phloem elements. 
The proximal part of the petiole is slightly different from the distal part. The 
petiole has wide, distinct wings and the petiole proper is somewhat circular with 
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slightly raised adaxial hump .The petiole is1.8mm thick and 1.55mm wide. The 
epidermis is thin; the cells are small and thick walled. The ground tissue is 
homogenous and parenchymatous (Fig 3.2).The vascular system consists of an arc of 
4 independent vascular bundles of which the median bundle is the largest and lateral 
bundles are collateral. The vascular bundles have long, parallel rows of xylem 
elements which are more compact. The xylem elements are wide, angular and thin 
walled. Phloem occurs on the lower part of the xylem strand comprising small groups 
of sieve elements. The lower part of the phloem band includes compact, small, 
angular parenchymatous cells.(Fig 4.1) 
Stomata 
            The stomata occur on the abaxial side of the lamina. They are located within 
pits which are enclosed by dense epidermis trichomes. The guard cells are widely 
elliptical measuring 25×20µm in size .The epidermis cells are thin walled, slightly 
wavy and polyhedral in outline (Fig 4.2). 
Venation pattern 
The major and minor veins become gradually thin forming dense, reticulate 
network. The vein-islets are wide and vary in shape from rectangular to polygonal in 
outline (Fig 5.1).The islets have distinct boundaries which are slightly wavy or 
straight .The vein-islet terminations are present in most of the islets. The terminations 
are thin, long and slightly wavy (Fig 5.2). 
Glandular trichomes 
Within the islets there are seen prominent 2 celled, elliptical, subsessile 
glandular trichomes (Fig 5.3).The trichomes have thin walls and cytoplasmic content. 
The glands are 45×20µm in size. The glands are random in distribution.                      
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QUANTITATIVE MICROSCOPY [55,56] 
Quantitative microscopy or determinations of some pharmacognostical 
parameters are useful for setting standards for crude drugs. Quantitative microscopy is 
used for evaluation of crude drugs. It includes vein islet number, vein termination 
number, stomatalnumber, stomatal index and palisade ratio. 
Stomatal number and stomatal index 
Stomatal number 
The average number of stomata per square millimetre of epidermis is termed 
as stomatal number. 
Stomatal index 
The percentage proportion of the ultimate divisions of the epidermis of a leaf 
which have been converted into stomata. 
Determination of stomatal number and stomatal index 
The replicas of leaf surface may be made which are satisfactory for the 
determination of stomatal number and stomatal index using fresh leaves. The 50% 
gelatin and water gel is liquefied on a hot slide. The fresh leaf is placed on it. Then the 
slide is inverted and cooled under tap water and after about 15-30 minutes the 
specimen is stripped off. The imprint on the gelatin gives clear outline of the 
epidermal cells, stomata and trichomes. The slide was examined under 45x objective 
and 10x eye piece to which a microscopical apparatus was attached. The stomatal 
index was calculated by using the formula 
Stomatal index  S.I.= 100x
SE
S
  
Where  
S = Number of stomata in 1sq mm area of leaf. 
E=Number of epidermal cells (including trichomes) in the same area of leaf. 
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Vein islet number 
The number of vein islets per mm2 calculated from four contiguous square 
millimeters in the central part of the lamina, midway between the midrib and the 
margin. 
Vein termination number 
The number of vein islet terminations per mm2 of leaf surface. An ultimate 
free termination of a veinlet or branch of a veinlet. 
Detemination of vein islets and vein termination number 
The fragment of leaf lamina with an area of not less than 1sq.mm.excluding 
the midrib and the margin of the leaf was taken. The fragments of leaf lamina were 
cleared by heating in a test tube containing chloral a temporary hydrate solution on a 
boiling water bath until clear. The clear fragments were stained with safranin solution 
and mount was prepared with glycerol solution. The stage micrometer placed on the 
microscopic stage, examined under10x objective lens and 6x eyepiece and an area of 
1 sq.mm. square was drawn. The cleared leaf piece was placed on the microscope 
stage, the vein islets and vein terminals included in the square was drawn. 
The number of vein islets and terminals within the square including those 
overlapping on two adjacent sides and excluding those intersected by results obtained 
in the number of vein islets and terminals in 1sq.mm.were tabulated in table 
Palisade ratio 
  The average number of palisade cells beneath each upper epidermal cell is 
termed as palisade ratio. 
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Determination of palisade ratio 
 Epidermal peeling was done by partial maceration by Jeffery‘s maceration 
fluid, were prepared. A fragment was transferred into a micro scopical slide and the 
mount of upper epidermis was prepared with a small drop of glycerol on one side of 
the cover slip to prevent the preparation from drying. The same was examined under 
45x objective and10x eyepiece. Four adjacent epidermal cells were traced. Focusing 
gently downward to bring the palisade cells into view and sufficient palisade cells to 
cover the outline . Four epidermal cells were then traced. The palisade cells under the 
epidermal cells were counted and the palisade ratio were calculated by using the 
following formula and the results were tabulated in table1   
Powder analysis [57,58] 
The behaviour of the powder with different chemical reagents was carried out 
as per standard  procedure mentioned by Kay(1938) and Johansen(1940) the 
observations are tabulated 
Flourescence analysis 
The fluorescent analysis of the crude drug of A.niagirica were carried out by 
usig the method of chase and pratt (1949)[5].The observations are tabulated in table 2 
Standardisation parameters  
The physical evaluations like the ash values, loss on drying, foreign organic 
matter and extractive values gives the clear idea about the crude drug under 
examination 
Determination of volatile oil [59] 
       Volatile oil apparatus was thoroughly washed and the glycerin was applied at 
both the ends. An accurately weighed 100g of plant material was crushed and 
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introduced into the flask containing distilled water until one third of the plant material 
was immersed and few pieces of porcelain bits were added. Small quantity of glycerin 
is also added. The flask containing liquid was heated until it boils. After 3hrs heating 
was stopped and the collected oil was recorded on the graduated receiver tube. Oil 
content of the plant material was calculated in ml/100g of plant material. 
Determination of foreign organic matter [59] 
  10gms of a drug powder was weighed and spread in a thin layer on a paper. It 
was examined under6X magnification .The foreign material was picked out and 
weighed. Then the percentage was calculated. 
Determination of moisture content [60] 
Loss on drying was noted for this drug .1gm of powdered drug was taken in a 
tarred petridish and it was weighed. The weighed drug powder was kept in hot air 
oven at 100-1050C for 1hr. Then it was cooled in a desiccator  and again weighed. 
The loss on drying was calculated with reference to the air dried powder.  
Ash content [61] 
  The residue remaining after incineration is the ash content of crude drug, 
which simply represents inorganic salts naturally occurring in the drug or adhering to 
it or deliberately added to it as a form of adulteration. 
Total ash  
2gms of the dried coarsely powdered drug was taken in a tarred crucible. The 
crucible was kept in a incinerator at 450oC .The drug becomes ash within one or two 
hrs and It was weighed. 
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Water soluble ash 
Total ash obtained by previous procedure was boiled with 25ml of distilled 
water. The insoluble matter was filtered in ash less filter paper, ignited to constant 
weight, cooled in a dessicator and weighed. The weight of the insoluble matter was 
subtracted from the weight of the ash taken. The difference gave the weight of the 
water soluble ash. 
Acid insoluble ash  
  Total ash obtained from the previous procedure was mixed with25ml of dilute 
hydrochloric acid and boiled for five minutes. The ash was filtered in a ashless filter 
paper. The filter paper with ash in a crucible is kept in an incinerator for one or two 
hours. Then the ash was weighed. 
DETERMINATION OF EXTRACTIVE VALUES [60,61] 
Ethanol extractive values 
5gms of the dried coarsely powdered drug was weighed and macerated with 
100ml of ethanol in a closed conical flask for 24hrs.It was frequently shaken for 
6hrs,then it was allowed to stand for 18 hrs. It was filtered rapidly. 25 ml of the 
filterate was taken in a tarred china dish and it was dried at 1050C to constant weight 
and weighed. The percentage was calculated with reference to the air dried powder. 
Methanol extractive values 
5gms of the dried coarsely powdered drug was weighed and macerated with 
100ml of methanol in a closed conical flask for 24hrs. It was frequently shaken for 
6hrs, then it was allowed to stand for 18 hrs. It was filtered rapidly. 25 ml of the 
filterate was taken in a tarred china dish and it was dried at 1050C to constant weight 
and weighed. The percentage was calculated with reference to the air dried powder.  
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Petroleum ether extractive value 
5gms of the dried coarsely powdered drug was weighed and macerated with 
100ml of petroleum ether in a closed conical flask for 24hrs.It was frequently shaken 
for 6hrs, then it was allowed to stand for 18 hrs. It was filtered rapidly. 25 ml of the 
filterate was taken in a tarred china dish and it was dried at 1050C to constant weight 
and weighed. The percentage was calculated with reference to the air dried powder. 
Chloroform extractive value 
5gms of the dried coarsely powdered drug was weighed and macerated with 
100ml of chloroform in a closed conical flask for 24hrs.It was frequently shaken for 
6hrs,then it was allowed to stand for 18 hrs. It was filtered rapidly. 25 ml of the 
filterate was taken in a tarred china dish and it was dried at 1050C to constant weight 
and weighed. The percentage was calculated with reference to the air dried powder. 
Ethyl acetate extractive value 
 5gms of the dried coarsely powdered drug was weighed and macerated with 
100ml of ethyl acetate in a closed conical flask for 24hrs.It was frequently shaken for 
6hrs,then it was allowed to stand for 18 hrs. It was filtered rapidly. 25 ml of the 
filterate was taken in a tarred china dish and it was dried at 1050C to constant weight 
and weighed. The percentage was calculated with reference to the air dried powder. 
Water soluble extractive value 
5gms of the dried coarsely powdered drug was weighed and macerated with 
100ml of chloroform water in a closed conical flask for 24hrs. It was frequently 
shaken for 6hrs, then it was allowed to stand for 18 hrs. It was filtered rapidly. 25 ml 
of the filterate was taken in a tarred china dish and it was dried at 1050C to constant 
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weight and weighed. The percentage was calculated with reference to the air dried 
powder. 
Determinations of foaming index [60 ] 
Plant materials contain saponins that can cause persistent foam when it was 
shaken as a aqueous decoction. The foaming ability of plant materials and their 
extracts was measured in terms of foaming index. 
An accurately weighed 1g of the coarse plant material was transferred into a 
500ml conical flask containing 100ml of boiling water. The flask was maintained at 
moderate boiling for 30 minutes .The solution was cooled and filtered into a100ml 
volumetric flask and sufficient distilled water was added to dilute to volume .The 
decoction was poured into 10 stoppered test tubes in successive portions of 1ml,2ml, 
etc., upto 10ml, and the volume of the liquid in each tube was adjusted with water up 
to 10ml.The tubes were stoppered and shaken in a length wise motion for 15sec (two 
shakes /sec) and allowed to stand for 15 minutes .The height of foam was measured 
.If the height of the foam in every tube was less than 1cm the foaming index. If this 
tube was first or second tube in a series, an intermediate dilution was prepared in a 
similar manner to obtain a more precise result. 
 If the height of the foam was more than1cm in every tube, the foaming index 
was over 1000. In this case, the determination was repeated using a new series 
dilution of the decoction in order to obtain a result. The foaming index was calculated 
using the following formula 1000/A, where A was the volume in ml of the decoction 
used for preparing the dilution in the tube where foaming to a height of 1cm was 
observed.  
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Determination of swelling index [60] 
Swelling index is the volume in ml taken up by the swelling of 1g of plant 
material under specified conditions .Its determination is based on the addition of 
water. Using a glass stoppered measuring cylinder, the material is shaken repeatedly 
for 1hr and then allowed to stand for required period of time. The volume of the 
mixture (in ml) is read. 
 About 1g of weighed powder was introduced introduced into a25ml glass 
stoppered measuring cylinder,25ml of water was  added and the mixture was shaken 
thoroughly every 10minutes for 1hr and allowed to stand for 3hrs at room 
temperature. The volume in ml occupied by the plant material including the sticky 
mucilage was measured. The mean value of the individual determination was 
calculated related to 1g of plant material and the result was tabulated in table 4. 
 
 
 
 
 
 
 
 
 
Fig.2. Dorsal view 
 
 
Fig.3. Ventral view 
 
 
Fig. 15. Habit and Habitat of Plant 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 16. Herbarium of Artemisia nilagirica 
 
 
 
 
Fig. 4. Fruits of Artemisia nilagirica 
 
Fig. 5. Flower of Artemisia nilagirica 
 
Fig. 5. Seeds 
 
Fig. 6. T.S.of Leaf through Midrib 
 
 
Fig. 7. T.S. of Midrib enlarged 
 
 
 
 
 
  
Fig. 8. T.S. Median and Lateral Veins on the Midrib enlarged 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Fig. 9. T.S of lamina through lateral vein 
 
 
 
 
 
 
 
 
 Fig. 10. T.S. of Lamina 
 
Fig.11. T.S. of Petiole through distal part 
 
 
 
 Fig. 12. T.S. of Petiole through Proximal part 
 
Fig. 13. Venation pattern 
 
 
 
 
 Fig. 14. Vein islet and vein termination enlarged 
 
 
 
 
 
 
 
 
 
 
 
 
Phytochemical Studies 
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PHYTOCHEMICAL EVALUATION 
                     Phytochemistry deals with natural product organic chemistry and plant 
biochemistry .It also deals with a variety of secondary metabolites that are produced 
by plants,their chemical structures ,biosynthesis, metabolism,natural distribution and 
biological functions.For these operations, methods are needed for separation, 
purification and identification of the many different constituents present in plants.  
                     The shadow dried leaves of Artemesia nilagirica were powdered and 
then subjected to the following preliminary phytochemical studies. 
Organoleptic evaluation 
                             Nature         -     Coarse powder 
                             Colour         -     Green 
                             Odour          -     Aromatic odour 
                             Taste           -     Aromatic sweet 
QUALITATIVE CHEMICAL EVALUATION[55,56] 
       The chemical nature, specific identity, polarity, etc of the substances in the crude 
extract can be determined by a number of ways including wet chemical tests. The 
chemical test can be useful for the investigation of the chemical compounds. The 
various tests  for steroids, terpenoids, flavones, anthraquinones, sugars, glycosides, 
alkaloids, phenols and tannins were performed on the extracts and the results were 
tabulated in table 5 
Test for sterols 
         The powdered leaf was first extracted with petroleum ether and evaporated to a 
residue. Then the residue was dissolved in chloroform and tested for sterols. 
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a.Salkowski test 
   A few drops of concentrated sulphuric acid was added to the above solution, 
shaken well and set aside. The lower chloroform layer of the solution turned red in 
colour indicating the presence of sterols. 
b.Libbermann-burchard’s test 
To the chloroform solution a few drops of acetic anhydride and 1ml of 
concentrated sulphuric acid were added through the sides of the test tube and set aside 
for a while. At the junction of two layers a brown ring was formed. The upper layer 
turned green indicating the presence of sterols. 
2.Test for carbohydrates 
a)Molisch’s test 
The aqueous extract of the powdered leaf was treated with 2-3 drops of 1% 
alcoholic α-naphthol and 2ml of concentrated sulphuric acid was added along the 
sides of the test tube .A purple colour indicates the presence of carbohydrates. 
b)Fehling’s test 
The aqueous extract of the powdered leaf was treated with Fehling’s solution I  
and II and heated on a boiling water bath for half an hour. A red precipitate was 
obtained indicating the presence of free reducing sugars. 
c)Benedict’s test 
The aqueous extract of the powdered leaf was treated with equal volume of 
Benedict’s reagent. A red precipitate was formed indicating the presence of reducing 
sugar. 
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3. Test for proteins  
a). Millon’s test 
A  small quantity acidulous-alcoholic extract of the powdered drug was heated 
with Millon’s reagent. A white precipitate turning red  on heating indicates the 
presence of proteins. 
b).Biuret test 
                    To one portion of acidulous-alcoholic extract of the powdered drug, one 
ml of 10%  solution of copper sulphate and sodium hydroxide was  added. Violet 
colour was obtained indicating the presence of proteins. 
Test for alkaloids 
                     About 2gm of the powdered material was mixed with 1gm of calcium 
hydroxide  and 5ml of water into a smooth paste and set aside for 5 minutes . It was 
then evaporated to dryness in a porcelain dish on a water bath and extracted with 
chloroform. Then it was filtered and the chloroform was evaporated. To this 5ml of 
dilute hydrochloric acid was added followed by 2ml of each of the following reagents  
a)Mayer’s test 
                      To small quantity of the extract add Mayer’s reagent. No cream colour 
precipitate indicates the absence of alkaloids. 
b)Dragendroff’s test 
                       To small quantity of the extract  dragendroff’s reagent was added .No 
orange brown precipitate indicates the absence of alkaloids. 
c)Wagner’s test 
                      To small quantity of the extract  Wagner’s reagent was added. No 
reddish brown precipitate indicates the absence of alkaloids. 
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d)Hager’s test 
                       To small quantity of extracts  Hager’s reagent was added. No yellow 
precipitate indicates the absence of alkaloids. 
5.Test for glycosides 
a.Borntrager’s test 
                        The powdered leaf was boiled with dilute sulphuric acid, filtered and to 
the filtrate benzene was added and shaken well. The organic layer was separated to 
which ammonia solution was added slowly. No pink colour in the ammoniacal layer 
indicates the absence of anthraquinone glycosides. 
b.Modified borntragers test 
                          About 0.1g of the powdered drug was boiled for 2minutes with dilute 
hydrochloric acid and few drops of ferric chloride solution, filtered while hot and 
cooled. The filtrate was then extracted with benzene and the benzene layer was 
separated. Equal volume of dilute ammonia solution was added to the benzene extract. 
No pink colour was observed in ammoniacal layer showing the absence of 
anthraquinone glycosides. 
c.Test for cardiac glycosides (for deoxysugar) 
 i) Keller kiliani test 
                  About 1g of the powdered leaf was boiled with 10ml of 70% alcohol for 2 
minutes, cooled and filtered. To the filtrate 10ml of water and 5 drops of solution of 
leads subacetate were added and filtered, evaporated to dryness. The residue was 
dissolved in 3ml of glacial acetic acid. To these 2 drops of ferric chloride solution was 
added. Then  concentrated sulphuric acid was added to the test tube carefully and 
observed. No reddish brown layer was observed indicating absence of deoxysugars of 
cardiac glycosides. 
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ii)Test for cyanogenetic glycosides 
                   Small quantity of the powder was placed in a stoppered conical flask  with 
just sufficient water, to cover it. A sodium picrate paper strip was inserted through the 
stopper so that it was suspended in the flask and it  was set aside for 2 hrs in a warm 
place. No brick red colour was produced on the paper indicating the absence of 
cyanogenetic glycosides. 
6.Test for saponins 
                    About 0.5g of the powdered drug was boiled gently for 2 minutes with 
20ml of water and filtered while hot and allowed to cool. 5ml of the filtrate was then 
diluted with water and shaken vigorously. Frothing was produced indicating the 
presence of saponins . 
7.Test for tannins  
                     A small quantity of the powdered drug was extracted with water. To the 
aqueous extract few drops of  ferric chloride solution was added. A bluish black 
colour was produced indicating the presence of tannins. 
8 Test for flavonoids 
Shinoda’stest 
                     A little of the powdered drug was heated with alcohol and filtered. To 
the test solution magnesium turnings and few drops of concentrated hydrochloric acid 
were added and boiled for five minutes. Red colour was obtained indicating the 
presence of flavonoids. 
Alkali test 
    To the small quantity  of test solution, 10% aqueous sodium hydroxide solution was  
added yellow orange colour was produced indicating the presence of flavonoids. 
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Acid test 
To the small quantity of test solution, few drops of concentrated sulphuric acid 
were added yellow to crimson colour was obtained indicates the presence of 
flavonoids. 
9.Test for terpenoids 
                     A little of the powdered leaf was extracted with chloroform and filtered. 
The filtrate was warmed gently with chloroform and thionylchloride. Pink colour 
solution appeared which indicated the presence of terpenoids. 
10.Test for the presence of volatile oil 
                     Weighed quantity (250 gm) of fresh leaves were extracted and subjected 
to hydrodistillation using volatile oil estimation apparatus. Volatile oil was obtained 
indicating the presence of volatile oil . 
11.Test for coumarins 
a) FeCl3 Test 
                       To the alcoholic extract of the drug , few drops of alcoholic FeCl3 were 
added. The formation of deep green colour turning yellow on the addition of 
concentrated nitric acid indicates the presence of coumarins. 
b) Flourescence test 
                        The alcoholic extract of crude extract was mixed with 1N NaOH 
solution. A blue green fluorescence indicates the presence of coumarins. 
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QUANTITATIVE ESTIMATION OF PHYTOCONSTITUENTS 
Preparation of methanolic extract of Artemisia nilagirica 
                         The shade dried and coarsely powdered leaves of Artemisia nilagirica 
was defatted with petroleum ether for three days by triple maceration. The defatted 
marc was extracted with methanol by triple maceration and filtered. The filtrate was 
concentrated under reduced pressure to obtain a solid residue which was dark green in 
colour. 
Estimations: 
Total phenol determination[63,64,65] 
             Phenols comprise the largest group of secondary metabolites. They are 
defined as compounds that have at least one hydroxyl group attached to benzene ring. 
Phenolic compounds are commonly found in plants and they have been reported to 
have multiple biological effects, including antioxidant activity 
Principle 
The total phenolic content of the various concentrations of extract of 
Artemisia nilagirica was determined by Folin-Ciocalteu reagent method. All the 
phenolic compounds are oxidized by the Folin-Ciocalteureagent. This reagent is 
reduced during oxidation of the phenolic substances, into a mixture of blue 
molybdenum and tungsten oxides. 
            The blue colour reduced has a maximum absorption at about 750-760nm.The 
absorption is proportional to the quantity of oxidized phenolic compounds. 
Instrument 
    Shimadzu UV Visible spectrophotometer model 1800. 
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Reagents required 
a) Folin-Ciocalteu Reagent (1N) 
The Folin-cioacalteu reagent is a mixture of phosphomolybdate and phospho 
tungstate. Commercially available Folin-Ciocalteu reagent (2N) was diluted with an 
equal volume of distilled water. The resultant solution was kept in a brown colour 
bottle and stored in refrigerator at 40C. 
b) Sodium carbonate solution (10%) 
Procedure 
To the 1ml(1mg/ml and 0.5 mg/ml) of methanolic extracts of Artemisia 
nilagirica, 0.5ml of Folin Ciocalteu reagent(1N) was added and allowed to stand for 
15 minutes. Then 1ml of 10% sodium carbonate solution was added to the above 
solution. Finally the mixtures were made upto 10ml with distilled water and allowed 
to stand for 30 minutes at room temperature and total phenols were determined 
spectrophotometrically at 760 nm. 
The calibration curve generated by preparing gallic acid at different 
concentration (2,4,6,8,10µg/ml).The reaction mixture without sample was used as 
blank. Total phenol content of various leaf extracts was expressed in terms of mg of 
gallic acid equivalent per gm extract(mg GAE/g). 
2. TOTAL FLAVONOID DETERMINATION[66,67] 
             The word ‘flavonoid’ is derived from the latin word, flavus meaning yellow 
and many flavonoids are indeed yellow in colour. It consists of a single benzene ring  
joined to a benzo gamma pyronestructure. These include  catechins, 
lecoanthocynanins, flavonones, flavones, flavonols, chalcones, aurones and 
isoflavones. 
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Principle 
               The aluminium chloride colorimetric technique was used for estimation of 
total flavonoid estimation. Aluminium ions form stable complexes with C4ketogroup 
and either to C3 or C5 hydroxyl groups of flavones and flavonols in acidic medium .It 
also forms acid labile complexes with ortho hydroxyl groups of flavones and 
flavonols in acidic medium. It also forms acid labile complexes with ortho hydroxyl 
groups in the A or B rings of flavonoids. These complexes showed a strong 
absorption at 415nm which is used for the estimation of flavonoids. 
Instrument 
Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents required 
    10% aluminium chloride 
    1M Potassium acetate 
Procedure 
1ml of methanolic extracts of Artemisia nilagirica 50µg/ml and 100µg/ml 
were taken and 0.1ml of aluminium chloride, 0.1ml of potassium acetate solution and 
2.8 ml of ethanol were added and the final volume was then made up to5ml with 
distilled water. After 20minutes, the absorbance was measured at 415nm. 
A calibration curve was constructed by plotting absorbance reading of 
quercetin at different concentrations. The sample without aluminium chloride was 
used as a blank. The total flavonoid content in the extract was expressed as milligrams 
of quercetin equivalent per gram of extract. 
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TOTAL TANNIN CONTENT DETERMINATION[69] 
Principle 
            Total tannin content of extract was determined by  folindenis reagent method. 
Tannin like compounds reduces phosphor tungsto molybdic acid in alkaline solution 
to produce a highly blue coloured solution and the intensity of which is proportional 
to the amount of tannins and estimated by spectrometer at 700nm 
Instrument  
Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents 
a) Folin Denis reagent 
b) Sodium carbonate 10% 
Procedure 
0.2ml of (1mg/ml) methanolic extracts of Dalbergiasissoo, was made upto 1ml with 
distilled water. Then add 0.5ml of Folin Denis reagent and allowed to stand for 
15minutes, then 1ml of sodium carbonate solution was added to the mixture  and it 
was made up to 5 ml with distilled water. The mixture was allowed to stand for 
30minutes at room temperature and the tannin content was determined 
spectrophotometrically at700nm. 
The calibration curve was generated by preparing tannic acid at different 
concentration (4,8,12,16,20µg/ml) The reaction mixture without sample was used as  
blank .The total tannin content in the leaf extract was expressed as milligram of  
tannic acid equivalent per gram of extract. 
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THIN LAYER CHROMATOGRAPHY [70] 
                In 1958,Stahl developed standard equipment for analyzing compound 
mixture  by thin layer chromatography .It combines the advantages of paper and 
column chromatography. It is a simple equipment. It has a short development time. It 
has a wide choice of stationary phase. It is possible to early recovery of separated 
components. It possess easy visualisation of separated components. 
Principle 
                The principle of separation is adsorption. A thin layer of adsorbent coated 
on a chromatographic plate is spotted by one or more components. The mobile phase 
solvent flows through because of capillary action. According to their affinities, the 
components move towards the adsorbent. The components with more affinity move 
slower. The component with less affinity move faster. Thus the components are 
separated on the basis of affinities. 
Procedure 
 Preparation of TLC plates 
                   It is based on pouring technique. The slurry is prepared by mixing the 
Silica Gel G with water at the ratio of 1:2 .It is poured on the glass plate having 
dimensions of 20X 20cm which is maintained on levelled surface. The slurry is 
uniformly spreaded on the plate. The plates are dried in a hot air oven at 1050C . Then 
it is kept in a dessicator. 
Application of the sample 
                    The methanolic extract of Artemisia nilagirica 2-5 of a 1% solution 
spotted on a plate using a capillary tube. The spot was kept 2cm above the base of the 
plate. 
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Mobile phase 
Ethyl acetate: Methanol: Water    100:6:4 
Development of chromatogram 
The glass plate is kept in the development glass tank which has mobile phase. 
The lower end above the surface of the solvent front has reached a suitable height. 
The glass plate is removed and dried in room temperature. The spot is identified in 
UV light at 365nm. 
Rf Value 
The Rf Value is calculated by the formula, 
Rf value = Distance travelled by solute 
                 Distance travelled by solvent 
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ISOLATION OF ACTIVE PRICIPLE BY COLUMN CHROMATOGRAPHY 
[79] 
The isolation of active principle from the methanolic extract of Artemisia 
nilagirica by Column chromatography. The column chromatography was first 
developed by the American petroleum chemist D.T.Day in 1900, M.S.Tswett and the 
Polish botanist in1906. 
Principle 
The rate of adsorption varies with a given adsorbent for different materials. 
This is the principle of selective adsorption. The mixture to be separated is dissolved 
in a suitable solvent and allowed to pass through a tube containing the adsorbent. The 
component which has greater affinity is adsorbed in the upper part of the column and 
the component which has lesser affinity is adsorbed in the lower part of the column. 
Materials Required 
 Column 
Silica gel (230-400mesh) 
Cotton 
Ethyl acetate AR grade 
 Hexane AR grade 
Methanol AR grade 
Precoated TLC plates 
Procedure 
Preparation of the column 
                   The glass column was placed in a ring stand in a vertical position. A plug 
of glass wool was pushed down to the bottom of the column. 22 g of silica gel was 
dissolved in approximately 50 ml of hexane to make a  slurry. Slurry of silica gel 
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(230-400 mesh, column chromatography grade) was prepared with a suitable solvent 
and poured gently into the column. The stop cock was opened and some solvent was 
allowed to drain out. The layer of solvent always covered the adsorbent to avoid 
development of cracks in the column. 
Pre-elution of the column      
              Hexane was added to the top of the silica gel. The solvent level was 
monitored, both as it was flowing through the silica gel and the level at the top. When 
the bottom solvent level was at the bottom of the column, the pre-elution process was 
completed and the column was ready to load. 
Sample loading 
The sample to be isolated was dissolved in a small amount of solvent, Hexane 
and loaded into the column. Once the sample was in the column, fresh eluting solvent 
was added to the top and hence the column was ready to begin the elution process. 
Elution of the column  
The solvent Hexane was allowed to flow through the column and fresh solvent 
was added as necessary. The coloured bands travelled down the column as the 
compound was being eluted. As soon as the coloured compound began to elute, the 
collection beaker was changed. 
Elution of the column with the second elution solvent 
As a mixture of compounds was being separated, the eluting solvent was 
changed to a more polar system by using an 80:20 mixture of Hexane and Ethyl 
acetate. All the collected fractions were subjected to analysis 
 
 
Fig. 1. Column Chromatography 
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FRACTIONS ELUTES 
NATURE OF 
RESIDUE 
No. OF SPOTS 
1-4 Hexane 100ml No residue - 
5-10 Hexane: pet ether 
90:10 
Green brown  3 
9-14 Hexane: Pet ether 
80:20 
Green brown 2 
5-18 Hexane: pet ether 
70:30 
Brown  2 
 
STRUCTURAL ELUCIDATION OF ACTIVE PRINCIPLE 
The structural elucidations of the active principle were performed by 
spectroscopical studies (UV, FTIR&NMR).The spectroscopic studies are based on the 
electromagnetic spectrum. 
ULTRA VIOLET ESTIMATION [71,72] 
UV spectroscopy is the study of absorption of Ultra violet radiation which 
ranges from 200nm to 400nm. It is based on Beer-Lamberts law. 
Principle  
The bonding and non bonding electrons absorb the radiation and undergo 
transition from ground state to excited state. By the characteristic absorption peaks, 
the nature of the electrons present and the molecular structure can be elucidated. 
Instrument 
Shimadzu UV Visible spectrophotometer, Model 1800 
Procedure 
The methanolic extract of Artemisia nilagirica 1mg/ml concentration was 
taken in the test tube. The wavelength was set as 360nm in a spectrophotometer. It 
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was adjusted to auto zero by methanol. The sample solution taken in a cuvette and 
placed in the UV and connect UV probe for observing peak. 
FOURIER TRANSFORM INFRARED SPECTROSCOPY [73]    
Infrared spectroscopy is one of the most powerful analytical techniques which 
offers possibility of structure elucidation and functional group determination. This 
technique coupled with intensity measurements is used for quantitative analysis 
Range of Infrared radiation 
 The photographic region-visible to 1.2µ 
 The very Near infrared region-1.2 to2.5µ 
 The near infrared region-25 to 25µ 
 The far infrared region-25 to 300-400. 
Principle [74] 
                 The atoms or groups of atoms are connected by bonds. These bonds are 
analogous to springs and not rigid in nature. It maintains some vibrations with some 
frequency, characteristic to every portion of the molecule, because of the continuous 
motion of the molecule. This is called the natural frequency of vibration. 
If, Applied infrared frequency = Natural frequency of vibration, 
Absorption of IR radiation takes place and a peak is observed. 
Instrument 
Alpha T Bruker optics FTIR spectrophotometer. 
Procedure[75] 
  1/8” solid sample was taken in a micro spatula with about0.25-0.50 mg ofKBr, 
It was mixed and grinded thoroughly with mortar and pestle. Sample was kept in a 
pellet press. It was pressed at 5000-10000 psi. The sample was carefully removed 
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from the die and placed in the sample holder of FTIR. Then the instrument was 
connected to the computer and the spectrum was run for observing peaks.  
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY 
Nuclear magnetic resonance is a branch of spectroscopy in which radio 
frequency waves induce transitions between magnetic energy levels of nuclei of a 
molecule. The first observations of NMR signals were observed by Purcell and Bloch 
in 1945. NMR is a technique that enables us to study the shape and structure of 
molecules. 
Principle [76] 
          Any proton or nucleus with odd mass number spins on its own axis. When 
energy in the form of Radiofrequency is applied and when, 
    Applied frequency = Precessional frequency 
Absorption of energy occurs and a NMR signal is recorded. Application of 
magnetic field and radio frequency is necessary to cause a NMR  Spectra. 
Instrument 
1H NMR Bruker Advance III 500MHz multinuclear FT-NMR Spectrometer 
instrument at CLRI was used for NMR analysis. 
Procedure for 13C NMR[77] 
The no. of transients for a 13C experiment is higher than that of a regular 
proton NMR. A minimum of 128 transients to obtain a good spectrum. Line 
broadening was used to obtain clear spectrum .Then the sample was placed for 
acquisition .Then the spectrum was run for the observing peaks. 
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Procedure for proton NMR 
This important and well established application of nuclear magnetic resonance 
will serve to illustrate some of the novel aspects of this method. To begin with , the 
NMR spectrometer must be tuned to a specific nucleus, in this case of proton .The 
actual procedure for obtaining the spectrum varies,but the simplest is referred to as the 
continuous wave (CW) method. A typical CW-spectrometer is shown in the diagram. 
A solution of the sample in a uniform 5mm glass tube is oriented between the poles of 
a powerful magnet, and is spun to average any magnetic field variations ,as well as 
tube imperfections .Radio frequency radiation of appropriate energy is broadcast into 
the sample from an antenna coil (colored red) .A receiver coil surrounds the sample 
tube , and emission of absorbed RF energy is monitored by dedicated electronic 
devices and a computer. An NMR spectrum is acquired by varying or sweeping the 
magnetic field over a small range while observing the RF signal from the sample. An 
equally effective technique is to vary the frequency of the RF radiation while holding 
the external field constant.   
HIGH PERFORMANCE (PRESSURE) LIQUID 
CHROMATOGRAPHY 
              HPLC is the speed at which separations take place. The diffusion of the 
column is reduced and resolution is improved, because of the decrease in time. This 
technique has improved performance when compared to column chromatography. 
Principle [78,80] 
The principle of separation in HPLC is adsorption. The resolving power of a 
chromatographic column increases with column length and the number of theoretical 
plates per unit length. The numbers of theoretical plates are related to the surface area 
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of the stationary phase. The better resolution is formed by the smaller particle size of 
the stationary phase. 
Procedure[81] 
           The sufficient solvent from the reservoir ensure to run was checked. The screw 
on the right hand side of the RCM was used to pressurize the column to 800psi. the 
solvent selector on the inlet manifold at the front of the pump was switched for 
running the solvent. The power to the pump was switched on and slowly increases the 
flow rate. The UV detector was switched on and set as zero .The Data moduler was 
switched on to set the date and time. The injector lever was switched on. The needle 
was wiped with tissue paper and sample was injected to the injector and at the same 
time press "inject" on the data module to start the data collection. The data module 
plots a real time chromatogram, and at the end of the run time (15 min) replots the 
chromatogram with details of retention time (RT), peak area (A or H) and relative 
areas of the peaks (conc). The flow is stopped slowly. The solvent selector was 
changed to flushing solvent and shut down. 
 
 
 
 
 
 
 
 
 
 
 
 
Pharmacological 
activities 
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PHARMACOLGICAL ACTIVITIES 
INVITRO ANTIOXIDANT ACTIVITIES [82] 
A variety of in-vitro chemical methods are being used to determine the 
antioxidant activity of products and ingredients, but questions regarding whether the 
results have any bearing on effectiveness in the human body are leading to 
development of additional methods that may be more appropriate for screening 
potential antioxidant ingredients. 
 
DPPH RADICAL SCAVENGING ACTIVITY[83] 
Principle 
                 The DPPH assay is the measurement of the free radical scavenging activity. 
DPPH molecules are stable free radical that contain unpaired electron. According to 
Blois et al method, the quantitative estimation of free radical scavenging activity is 
determined. When the solution of DPPH is mixed with a substance  that can donate a 
hydrogen atom , it is converted to its reduced form The result was expressed in  IC50 
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Materials required 
1.Methanolic extract of Artemisia nilagirica 
2.2,2-diphenyl-1-picryl hydrazyl (DPPH) assay 
3.95% Ethanol 
4.Ascorbic acid 
Instrument 
Shimadzu UV Visible spectrophotometer, model 1800 
Procedure 
The stock solution of DPPH was prepared in ethanol (4mg/100ml).To  1ml of 
test samples of different concentrations 4ml of DPPH was added. Control without test 
compound was prepared in an identical manner. Blank was prepared in the similar 
way, where DPPH was replaced by ethanol. The  reaction was allowed to completed 
in the dark for about 30 minutes.Then the absorbance of test mixtures was read at 517 
nm. The percentage inhibition was calculated and expressed as percent scavenging of 
DPPH radical Ascorbic acid was used as standard. 
The percentage scavenging was calculated using the formula 
  % inhibition =(Acontrol– Asample)/Acontrol×100 
The concentration of the sample required for 50% reduction in absorbance 
(IC50) was calculated using linear regression analysis. The results obtained were 
tabulated. 
HYDROGEN PEROXIDE METHOD[84] 
Principle 
       The radical scavenging activity of plant extract against hydrogen peroxide   
was determined by using the method of Janani et al. The principle is based on the 
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capacity of the extracts to decompose the hydrogen peroxide to water.H2O2 in the 
presence of  O2 - can generate highly reactive OH hydroxyl radicals via the metal, the 
scavenging of hydrogen peroxide in cells is to avoid oxidative damage. Thus the 
scavenging of hydrogen peroxide  is an important antioxidant defence mechanism. 
Fe2++H2O2 →Fe3+ + OH + 
 The decomposition of hydrogen peroxide to water involves the transfer of  electrons 
as in equation  
H2O2+ 2H++2e-  →2H2O 
Reagents 
6% Hydrogen peroxide diluted with water in the ratio of 1:10 
0.1M,pH7.4 phosphate buffer 
Instrument  
Shimadzu UV Visible spectrophotometer, model 1800 
Procedure 
     To 1ml of test solutions at different concentrations, 3.8ml of 0.1M phosphate 
buffer solution( pH 7.4 ) was added and then mixed with 0.2ml of hydrogen peroxide 
solution. The absorbance of the reaction mixture was measured at 230nm after 10 
minutes .The reaction mixture without sample was used as blank .Sample blank was 
also prepared without reagents. Ascorbic acid was used as standard. The% inhibition 
of hydrogen peroxide was calculated using the formula  
                                     % inhibition = (Acontrol– Asample)/Acontrol×100 
The concentration of the sample required 50% reduction in absorbance (IC50) 
was calculated using regression analysis 
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ANTIOXIDANT ACTIVITY USING COD LIVER OIL [85,86] 
           The in-vitro antioxidant activity  using  cod liver oil was determined by the 
method of  Lee et al, 2002.According to Diplock 1997, the antioxidant action may be 
attributed to various mechanisms, some of which may be prevention of chain 
initiation, decomposition of peroxides, prevention of continued hydrogen abstraction 
and radical scavenging action. 
Principle 
Antilipid  peroxidation activity was evaluated using cod liver oil as substrate 
and effects of methanolic extract of Artemisia nilagirica were found to be dose 
dependent. When the ferrous ion is added, it induces the lipid peroxidation in oil. Per 
oxidation induction by ferrous ions takes place by the formation of ferry -per ferryl 
complex  through Fenton’s reaction 
Fe2+ + H2 O2    →Fe3+ +.OH +OH- 
Fe3+  +H2 O2   →Fe2++.OOH +H+ 
  Hydroxyl radicals were generated by Fenton’s reaction using an ammonium 
thiocyanate assay system. 
Reagents  
Cod liver oil 
Ammonium thiocyanate 
50 m M Phosphate buffer 7.4 
70% ethanol 
Ammonium thiocyanate 
Ferrous chloride 
Methanolic extract of Artemisia nilagirica 
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Procedure 
        The antioxidant activity of methanolic extract of Artemisia nilagirica against 
lipid per oxidation was measured by ammonium thiocyanate assay. The sample 
solution was 400µl of methanolic extract of A.nilagirica (6µg to 10µg) ,200 µl of 
diluted cod liver oil(25mg/ml of 99% Ethanol), 400µl of 50m M phosphate buffer 
(pH7.4) incubated for 15 minutes at 400C . From this solution 100µl of aliquot was 
mixed with 3ml of 70% ethanol, 100µl of ammonium thiocyanate (300mg/ml in 
distilled water) and 100µl of ferrous chloride (2.4 mg/ml in 3.5%HCl) solution is 
incubated at room temperature for 3 minutes. Absorbance is measured at 500nm. 
Control was measured without sample. 
 The % inhibition was calculated by  
% inhibition = (Acontrol - ASample)/AcontrolΧ 100 
The concentration of the sample required for 50% reduction in absorbance 
(IC50) was calculated using regression analysis. 
INVIVO ANTIOXIDANT ACTIVITIES 
LIPID PEROXIDATION[87] 
 Lipid peroxidation can be defined as the oxidative deterioration of lipids 
containing a number of carbon-carbon double bonds Lipid peroxidation is a well 
established mechanism of cellular injury in cellular injury in both plants and animals, 
and is used as an indicator of oxidative stress in cells and tissues. Lipid peroxides are 
unstable and decompose to form a compounds including reactive carbonyl compounds. 
A large number of toxic products formed during lipid peroxidation. These have effect 
on site away from area of their generation. Hence they behave as a toxic ‘second 
messengers’. Membrane lipids are particularly susceptible to lipid peroxidation. since 
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membrane from the basis of many cellular organelles like mitochondria, plasma 
membranes, endoplasmic reticulum, lysosomes, peroxisomes, etc., damage caused by 
the LP is highly detrimental to functioning of the cell and its survival. 
Principle  
 Lipid peroxidation is a well-established mechanism of cellular injury in both 
plants and animals, and isused as an indicator of oxidative stress in cells and tissues. 
Lipid peroxides are unstable and decompose to form a complex series of compounds 
including reactive carbonyl compounds. Polyunsatured fatty acid peroxides generate 
malondialdehyde (MDA) upon decomposition. The measurement of MDA is used as an 
indicator of lipid peroxidation.  The lipid peroxidation assay is based on the reaction of 
a chromogenic reagent,N-methyl-2-phenylindole with MDA  at 450C.One molecule of 
either MDA reacts with 2 molecules of reagent  to yield a stable chromophore with 
maximal absorbance at525 nm.  
Procedure 
 Separated liver tissues were weighed and homogenized in ice-cold 0.01M Tris-
HCl (pH 7.4), and then centrifuged, at 12,000 g for 15 min as described by Kavutcu et 
al. [115]. The concentrations of liver LPO were determined by estimating 
malondialdehyde (MDA) using the thiobarbituric acid test at absorbance 525 nm, as nM 
of MDA/mg protein [116]. 
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GSH ASSAY[88-93] 
 Glutathione (GSH) is a tripeptide (y – glutamylcysteinylglycine ) widely 
distributed in both plants and animals. GSH serves as a nucleophile co-substrate to 
glutathione transferases in the detoxification of xenobiotics and is an essential 
electron donor to glutathione peroxidases in the reduction of hydro peroxides. GSH 
involved in amino acid transport and maintenance of protein sulfhydryl reduction 
status. Concentration of GSH ranges from a few micromolar in plasma to several 
millimolar 
Principle 
 The Glutathione Reductase Assay Kit enables the spectrophotometric 
measurement of glutathione reductase activity by the increase in absorbance caused 
by the reduction of DTNB [5,5¢-dithiobis(2-nitrobenzoic acid)] at 412 nm 
(Colorimetric assay) .This assay is based on the reduction of glutathione (GSSG) by 
NADPH in the presence of glutathione reductase. In addition, 5, 5¢-dithiobis(2-
nitrobenzoic acid) [DTNB] reacts with the reduced glutathione (GSH) formed: 
                                 GR 
NADPH + H+ GSSG → NADP + 2 GSH 
The reduced glutathione can then spontaneously react with DTNB: 
GSH + DTNB → GS-TNB + TNB 
TNB = 5-thio(2-nitrobenzoic acid) 
 The reaction is measured by the increase in absorbance at 412 nm using an 
extinction coefficient (emM) of 14.15 for TNB. 
 Colorimetric assay - One unit will cause the reduction of 1.0 mmole of DTNB 
to TNB at 25 °C at pH 7.5. 
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 The concentration of enzyme can be calculated using the formula: 
units/ml = (DAsample - DAblank) x (dilution factor)/ 
εmM x (volume of sample in ml) 
For TNB6 
εmM = 14.15 mM-1cm 
Assay Procedure 
1. Assay Buffer and 2 mM Oxidized Glutathione Solution at 25 °C for at least 10 
minutes was equilibrated before starting the assay. 
2.  The kinetic program in the spectrophotometer wassetted. The following programs 
are recommended: 
Colorimetric assay 
Wavelength: 412 nm 
Initial delay: 60 seconds 
Interval: 10 seconds 
Number of readings: 11 
3. The spectrophotometer with a cuvette filled with water was made autozero. 
4. The following solution volumes in a 1 ml quartz cuvette in the order shown in table 
were placed. 
S.No. SOLUTIONS  COLORIMETRIC ASSAY 
1 2 mM Oxidized Glutathione 500 µl 
2 Assay Buffer 50-150 µl 
3 Sample 0-100µl 
4 3 mM DTNB 250 µl 
5 2 mM NADPH 50 µl 
 Total volume 1.00 ml 
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For both (UV and Colorimetric) assays perform a positive control by adding 10 to 20 
ml of the Glutathione Reductase Positive Control Solution per control reaction 2 mM 
NADPH Solution - Dissolve a portion of the b-Nicotinamide adenine dinucleotide 
phosphate, reduced (NADPH) at 1.85 mg/ml in Assay Buffer to prepare a working 
solution of 2 mM. Store at 4 °C. Prepare the NADPH solution fresh every day 
5. Liver tissue homogenates were mixed with 0.1mL of 25% trichloroacetic acid 
(Merck, CA, USA), and then centrifuged at 4,200 rpm for 40 min at 4◦C. Glutathione 
(GSH) contents were measured at absorbance 412nm using 2-nitrobenzoic acid 
6. The reaction with Assay Buffer instead of enzyme sample solution was run as a 
blank. 
7. The amount of enzyme in the sample was calculated  
 
SUPER OXIDE DISMUTASE ASSAY 
Principle[94] 
   The SOD activity is based on inhibition of nitrobluetetrazolium( NBT) 
reduction. Illumination of riboflavin in the presence of O2 and electro donor like 
methionine generates superoxide  anions and this has been used as a basis of SOD 
assay. The reduction of NBT by superoxide radicals to blue colouredformazan  was 
followed at 560nm .  
     One unit of SOD activity is defined as that amount of enzyme required to inhibit 
the reduction of NBT by 50% under specified conditions.   
2O2- + 2H+→ O2+H2O2 
Calculation 
Units/mg=1000/µg enzyme resulting in ½ maximum inhibition 
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Reagents 
 0.067 M Potassium phosphate buffer, pH 7.8 
 M Ethylene diaminetetraacetic acid (EDTA) containing 0.3 mM sodium  
cyanide 
 0.12 mM Riboflavin (store cold in a dark bottle) 
 1.5 mMNitrobluetetrazolium (NBT) (store cold) 
Procedure 
A series of samples ranging from 0.1-10 micrograms is recommended. A tube 
containing approximately 100 micrograms will generally produce maximum 
inhibition. the tubes in a light box providing uniform light intensity were placed (A 
foil-lined box approximately 4' long X 8" X 6" with an internally mounted 40 W 
fluorescent bulb has been used successfully).  The tubes were incubated for 5-8 
minutes to achieve a standard temperature. The0.05 ml riboflavin was added atzero 
time and at time intervals.  All tubes were incubated in the light box for 12 minutes 
and at timed intervals read A560. The percent inhibition of NBT reduction was 
determined. SOD estimation was based on the generation of superoxide radicals 
produced by xanthine and xanthine oxidase, which react with nitrotetrazolium blue to 
form formazan dye. SOD activity was then measured at 560nm by the degree of 
inhibition of this reaction, and was expressed as U/mg protein. 
 
CATALASE ACTIVITY 
Principle  
Decomposition of H2O2 in the presence of catalase was followed at 240nm 
[24]. Catalase activity was defined as the amount of enzyme required to decompose 
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1nM of H2O2 per minute, at 25◦C and pH 7.8. Results were expressed as U/mg 
protein. 
Calculation  
Units/mg =ΔA240/min Χ 1000/ 43.6 Χmg enzyme /ml reaction mixture 
Reagents 
 0.05 M Potassium phosphate, pH 7.0 
 0.059 M Hydrogen peroxide (30%) in 0.05 M potassium phosphate, pH 
7.0 
Procedure 
 The spectrophotometer was adjusted to 240 nm and 25°C. 
 The following reagents were pipetted 
Reagent grade water 1.9 ml 
0.059 M Hydrogen peroxide 1.0 ml
 
It was incubated in spectrophotometer for 4-5 minutes to achieve temperature 
equilibration and to establish blank rate if any. Add 0.1 ml of diluted enzyme and 
record decrease in absorbance at 240 nm for 2-3 minutes. The ∆A240/min from the 
initial (45 second) linear portion of the curve was calculated 
ANTITHYROID ACTIVITY 
Thyroid hormones play an important role in development, metabolism, 
thermoregulation, and growth [96]. However, under several pathological conditions 
like Graves’ disease, tumors of thyroid and pituitary gland stimulate thyroid cells to 
produce more hormones, which results in a hyperthyroid state [97]. Alterations in the 
level of these hormones lead not only to altered basal metabolic rate but also to many 
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health problems. Particularly, hyperthyroidism, if not treated properly, sometimes 
ends up with the common health problems such as diabetes mellitus and 
cardiovascular diseases [98]. Resemble to the human hyperthyroidisms were easily 
achieved in rodents by continuous treatment of l-thyroxine (LT4), a synthetic form of 
thyroid hormone [97,98] .Hyperthyroidism leads to oxidative damage of liver [99], 
osteoporosis [100], heart failure [101] and increased risk of heart attack [102] 
1.Materials and Methods 
Animals and Experimental Design. 
Adult Female Sprague-Dawely rats (6-wk old) weighing 190–240 g were used 
in the experiments   after allowing 28 days acclimatization. The animals were 
allocated four per polycarbonate cage in a temperature (20–25◦C) and humidity (40–
45%) controlled room. The light : dark cycle was 12 hr : 12 hr and normal rodent 
pellet diet and water were supplied during acclimatization, free to access.  After 
acclimatization, hyperthyroidism was achieved by daily subcutaneous injection of 
LT4 (Sigma, MO, USA) at a dose of 0.3mg/kg for 12 consecutive days according to 
the previous established method [98], and animals were randomly divided into 5 
groups of 6 rats each after 12th LT4 treatment; intact control, LT4 control, PTU 
(Sigma, MO, USA) 10 mg/kg, MEAN extracts 150 and 250mg/kg treated groups. 
PTU 10 mg/kg was also selected based on the previous in vivo efficacy test on the 
LT4-induced hyperthyroidisms in rodents [97,98]. MEAN extract was orally 
administered once a day for 15 days from 12th LT4 treatment, in a volume of 5 
mL/kg, dissolved in 1% CMC, and PTU was intraperitoneally injected, in a volume of 
5 mL/kg, dissolved in saline. All animals were overnight fasted before first LT4 and 
test material treatment with sacrifice. Equal volume of saline was subcutaneously 
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treated in intact control rats instead of LT4, and equal volume of distilled water was 
orally administered in intact and LT4 control rats, instead of MEAN extracts or PTU. 
ESTIMATION OF TSH, T3 AND T4 BY RADIOIMMUNOASSAY  
 Hyperthyroid state is accompanied with an increase in pro oxidant to 
antioxidants ratio, that promotes accumulation of oxidatively damaged molecules 
which leads to oxidative stress [103]. Among them liver is a major target organ for 
thyroid hormone with important biological and medical implications [104], and the 
atrophic changes and decreases of body fat masses were accompanied with 
bodyweight decreases [105–106]. These hyperthyroidisms with relative organ 
damages have been ameliorated by treatment of various antioxidants [97, 103 108, 
109]. 
Propylthiouracil (PTU) is a thioamide drug used to treat hyperthyroidism by 
decreasing the amount of thyroid hormone produced by the thyroid gland [110], and it 
also inhibited the enzyme deiodinase, which converts thyroxine (T4) to the active 
form triiodothyronine (T3) [111].Therefore, PTU has been selected as a potential 
reference drug for developing a new agent to treat hyperthyroidisms, and it potential 
inhibited LT4-induced hyperthyroidisms in rats and showed constant antioxidant 
effects at 10 mg/kg levels [3, 4]. However, the usages of PTU have been limited 
because of notable side effects include a risk of a granulocytosis in clinics [112]. 
Principle 
This assay is based on the competition between TSH, T3, T4and (T3 analog 
bound to biotinylated carrier protein) for a limited number of binding sites on 125I-
labelled monoclonal anti-triiodothyronine antibodies (tracer). Allowing to react a 
fixed amount of conjugate and antibody with different amounts of ligand the 
radioactivity measured on the solid phase will be inversely proportional to the 
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concentration of ligand.  During  a 2-hour incubation period with continuous agitation 
immuno-complex is immobilized on the reactive surface of test tubes. Decanting the 
supernatant from all tubes the radioactivity in tubes can be measured in a gamma 
counter.  
The average counts per minute (CPM) for each pair of assay tubes  was 
calculated the percent B0 / T for zero standard (S1) was calculated  by using the 
following equation: 
            S1 (cpm)  
B0 / T % =  ———   x100 
            T (cpm) 
 
Calculate the normalised percent binding for each standard, control and sample 
respectively by using the following equation: 
               S2-6 [C, Sx] (cpm)  
B / B0 =  —————————   x 100 
               S1 (cpm) T (cpm)  
 
For simplicity, these values are uncorrected for non-specific binding (NSB). 
This is enabled by low NSB being less than 1.5% of total count (using magnetic 
separator).   
 Contents of the kit 
1 vial 125I-TRACER(55ml), containing about 300 kBq 125I-labelled monoclonal 
antibody in buffer with 0.1% NaN3. 
6 vials STANDARDS 
0.5 ml per vial, containing 0 (S1), 2 (S2), 5 (S3), 10 (S4), 20 (S5) and 40 (S6) pmol/l 
FT3 in human serum with 0.1% NaN3 
1 vial CONJUGATE(55ml),ready to use containing conjugate in buffer with 0.1% 
NaN3. Do not expose to direct sunlight. 
1 vial CONTROLSERUM 
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Lyophilized human serum with 0.1%NaN3.The concentration of the control serum is 
specified in the quality certificate enclosed. 
2boxes COATED TUBE, ready to use. 2 x 50 reactive test tubes, 12x75 mm, packed 
in plastic boxes. 
Equipment required 
Test tube rack 
Precision pipettes with disposable tips (100 and 500 µl) 
Vortex mixer  
Centrifuge 
Plastic foil 
Absorbent tissue 
Gamma counter 
Preparation of reagents 
Add 500 µl distilled water to the lyophilised control serum. Mix gently with 
shaking or vortexing (foaming should be avoided). Ensure that complete dissolution is 
achieved, and allow the solution to equilibrate at room temperature for at least 20 
minutes. 
Specimen collection and storage 
Serum samples can be prepared according to common procedures used 
routinely in clinical laboratory practice. Sera can be stored at 2-8 °C for two days 
after collection. For later analysis they should be stored deep-frozen (-20 °C). 
Repeated freezing and thawing should be avoided 
Procedure 
6mL of blood samples were collected into evacuated tubes, and serum was 
separated by centrifugation at 3000 rpm for 10 min at 4◦C. Separated serum was 
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stored at −20◦C before analysis .Count each tube for at least 60 seconds in a gamma 
counter. The  serum FT3,FT4, and FTSH were analysed by  RIA KIT  
ANTIHYPERGLYCEMIC ACTIVITY 
Glucose oxidase method for  serum glucose estimation 
Principle 
Glucose oxidase catalyses oxidation of glucose to gluconic acid. The formed 
hydrogen peroxide is detected by chromogenic oxygen acceptor 
phenolaminophenazone in the presence of peroxidase 
α-D-glucose → β-D- glucose 
β-D-glucose+H2O+O2→D-gluconic acid +H2O2 
H2O2+4-amino phenazone+phenol→Quinonemine+4H2O 
The intensity of the colour formed is proportional to the glucose concentration 
in the sample. 
Materials and methods  
     Blood serum  
     Buffer phenolaminophenazone 
Instrumentation 
Shimadzu UV Visible spectrophotometer model 1800 
Procedure 
The wavelength is adjusted to 505nm at 370C. The instrument is set to auto 
zero. The sample, standard and control were incubated for 10 minutes at room 
temperature. The absorbance is readed. 
Calculations 
(A) sample/(A) standard Χ 100(Standard concentration)= mg/dl glucose in the 
sample. 
 
 
 
 
Results and 
Discussions 
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RESULTS AND DISCUSSION 
Morphological evaluation 
Interpretations of its morphological characters based on organoleptic and wide 
morphological characters showed that the leaf arrangement is   opposite to one 
another, lobed, laciniate or pinnatipartite and 5-14cm long. The flowers are many 
petaled which are small pale yellow and have a pleasant aroma. The fruits are 
achenes. 
Microscopical evaluation 
Microscopical evaluation helps magnifying the fine structure of minute objects 
and there by confirm the structural details of plant drug and thus offer supporting 
evidence when combined with other analytical parameters based upon their cell types 
and cell inclusion details etc., 
a) The leaf has thick midrib and thin lamina 
b) The epidermis of the midrib is very thin and the cells are not much distinct. 
c) The lateral vein is 320µm thick and 200µm wide 
d) The lamina is bifacial and the adaxial epidermal cells are 20µm thick. 
e) The petiole is 800µm thick and adaxial part is 500µm wide and abaxial part is 
750µm wide. The petiole is lobed and the upper part is semicircular. 
f) The stomata are anamocytic which are enclosed by dense epidermal trichomes. 
g) The venation is reticulate, vein islets are wide and the terminations are thin, and 
wavy 
h) The evaluation of powder microscopy showed two celled glandular trichomes, 
collenchymas cells and palisade mesophyll. 
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S.No. Parameters Values obtained 
1. Stomatal number in lower 
epidermis 
59.8±0.416 
2. Stomatal index in lower epidermis 18.41±0.140 
3. Vein islet number 11.583±0.1332 
 
4. Vein termination number 14.120±0.1910 
 
5. Palisade ratioin upper epidermis 9.25±0.70 
Mean of 10 readings ±SEM 
Fluorescence analysis 
The organic molecules absorb light usually over a specific range of wave 
length and many of them such radiations So if the powder is treated with different 
chemical reagents and seen under UV light, different colors was produced. 
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FLUORESCENCE ANALYSIS OF POWDER OF A. nilagirica Table2 
S.No Powder + analysis Daylight UV 254nm UV365nm 
1 Drug powder Green Green Yellow  
2 Drug powder+  aqueous 1 
M NaOH 
Green  Green  Green  
3 Drug +alcoholic 1M 
NaOH 
Green  Green  Yellow  
4 Drug powder+ iodine  Green  Green  Green  
5 Drug powder+ 10%KOH Green Green Yellow 
6 Drug powder+1MHCl Green  Green  Green  
7 Drug powder +glacial 
acetic acid 
Green   Yellow  Yellow  
8 Drug powder+ 
50%H2SO4 
Green  Green  Yellow  
9 Drug powder+50%HNO3 Green Green  Yellow  
10 Drug powder + 50% HCl Green  Yellow Yellow  
 
Therefore it can be used for the identification of the drug .The fluorescent 
characteristic of the drug  powder with different chemical reagent was studied by 
observing under UVlight 254and365 nm .The test and observations were recorded .It 
suggested that a non- fluorescent compound may fluorescent if it mixed with 
impurities . So the results obtained from the present fluorescent studies help to check 
any impurities present in leaf powder of Artemisia nilagirica. 
Determination of moisture content 
The loss on drying of plant materials should be determined and the water 
content should be controlled. This is especially important for materials that absorb the 
moisture easily and quickly deteriorate quickly in presence of water. The test 
determines both water and volatile matter. 
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Foreign organic matter 
Drugs should be free from moulds, insects, animal faecal matter and other 
contaminations such as earth materials, stone and extraneous materials. The amount 
of foreign matter shall not be more the percentage prescribed in the monograph.  
Determination of volatile oil 
          The fresh leaves of A.nilagiria were used for determination of volatile oil using 
Clevenger apparatus. It was calculated in ml and tabulated. 
ASH VALUE 
The residue remaining left after incineration of the crude drug is called as ash. 
The residue obtained usually represents the inorganic salts that are naturally occurring 
in the drug adhering to it. It varies with in definite limits according to the soils. It may 
also include inorganic matters deliberately added for the purpose of adulteration. 
Hence, an ash value determination furnishes the basis for judging identity and 
cleanliness of any drug and gives information relative to its adulteration or 
contamination with organic matter, thus ash values are helpful in determining the 
quality and purity of the drug. 
    The total ash of a crude drug reflects the care taken in its preparation. The acid 
insoluble in dilute hydrochloric acid. A higher limit of acid insoluble ash is imposed; 
especially the calcium oxalate content of the drug is higher. Water soluble ash is the 
water soluble portion of the total ash. These ash values are important quantitative 
standards. 
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PHYSICAL PARAMETERS  Table3 
S.No PARAMETERS Values expressed  as% 
1 Volatile oil 0.5ml 
2 Foreign organic matter 0.2 ±0.0001 
3 Moisture content 0.891±0.0617 
4 ASH VALUES  
a Total ash 14.07±0.0052 
b Water soluble ash 6.87±0.0091 
c Acid insoluble ash 1.91±.0035 
 
EXTRACTIVE VALUES 
The extractive values were calculated for different extracts like methanol, 
ethanol, pet ether, aqueous, ethyl acetate and chloroform. Aqueous extract has higher 
value because of contamination methanol extract was preferred.   
Table 4 
S.No.                 Parameters Values expressed as % 
1 Extractive values  
 Methanol extract 21.648±0.71234 
 Ethanol extract 11.68±0.092376 
 Pet ether extract 19.8933±1.2327 
 Chloroform extract 11.12±1.1199 
 Ethyl acetate extract 9.7066±1.6591 
 Aqueous extract 31.0933±1.8511 
 Foaming index More than 100 
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PHYTOCHEMICAL SCREENING OF Artemisia nilagirica 
The results obtained for investigation on phytochemical analysis of various 
extracts are presented in table. The methanolic extract showed the presence of a 
flavonoids, tannins, saponins and coumarins.None of the extract shows alkaloids, 
amino acids and glycosides 
Table 5 
S.No TEST ETHANOL AQUEOUS METHANOL PET ETHER 
1 Alkaloids - - - - 
2 Amino acids - - - - 
3 Carbohydrates - + - - 
4 Flavonoids + + + + 
5 Glycosides - - - - 
6 Coumarins + + + + 
7 Tannins + + + - 
8 Saponins + + + - 
9 Terpenoids - - - + 
10 Volatile oil - + - + 
11 Sterols - - - + 
 
ESTIMATION OF PHENOLIC CONTENT 
In the present study, total phenolic content in extract was estimated using 
modified Folinciocalteu method. Values are expressed as gallic acid equivalents and 
the results are tabulated. The total phenolic content for methanolic extract of 
Artemisia nilagirica were found to be117.4525mg/g of extract. 
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 The linear regression equation was found to be y=0.116x-0.004 while the 
correlation was found to be 0. 
998.The amount of phenolic content present in the extract were found to be by 
using above linear regression analysis  
Table 6 
 
 
 
S.No. 
Conc.of 
gallic acid 
µg/ml 
Absorbance 
at 760nm 
Conc.of 
methanolic 
extract µg/ml 
Absorbance 
at 760nm 
Amount of 
total phenolic 
content in 
terms mg 
GAE/g of 
extract 
1 20 0.229±0.010
 
50 
0.694±0.099 108.746±1.216
2 40 0.452±0.006 100 1.190±0.0751 
126.159 
±0.8160 
3 60 0.695±0.005    
4 80 0.918±0.031    
5 100 1.162±0.028    
    Average 117.45±1.016 
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Phenolic compounds are secondary metabolites that are derivatives of the 
pentose phosphate, shikimate, and phenylpropanoid pathways in plants.1-3 Phenolics 
are antioxidants with redox properties, which allow them to act as reducing agents, 
hydrogen donators, and singlet oxygen quenchers.4 They have also metal chelation 
properties. 
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ESTIMATION OF FLAVONOID CONTENT 
Flavonoids are a group of poly phenolic compounds with known properties 
which include free radical scavenging, inhibition of hydrolytic and oxidative enzymes 
and anti-inflammatory action. some evidence suggests that the biological actions of 
these compounds are related to their antioxidant activity.the total flavonoid content   
of methanolic extract was found to be 84.299 mg/g of extract. 
Table 7 
S.No. 
Conc.of 
quercetin 
µg/ml 
Absorbance
at 415nm 
Conc.  of 
methanoli
c extract 
in µg/ml 
Absorbance 
at 415nm 
Amount of 
flavonoid content 
in  terms mg 
quercetin 
equivalent/g  of 
extract 
1 20 0.589±0.01 50 0.0753±0.0021 77.22±00711 
2 40 1.151±0.04 100 0.237±0.0093 91.378±0.3046 
3 60 1.710±0.09    
4 80 2.390±0.03    
5 100 3.112±0.03    
    Average 84.299±0.18 
 
the linear regression equation was found to y=0.0307x+ 0.0432 while the correlation 
was found to be 0.9974the amount of phenolic content present in the extract were 
found to be by using above linear regression 84.299±0.1878 mg/g of extract. 
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. 
 Flavonoids are known for their free radical scavenging and anti- oxidant activities, 
the positions of the substituents also affect the physiological properties of different 
flavonoids. The flavonols having orto or para hydroxyl group in the 2- phenyl ring are 
known. 
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ESTIMATION OF TANNIN CONTENT 
Total tannin determination was carried out by spectrophotometry after 
oxidation of the analyte with a theFolindenis reagent in alkaline medium. This method 
is based on the redox reactions and reducing agents in sample. 
Total tannin content for methanolic extract of leaves of Artemisia nilagirica 
was found to be 757 .50 ±3.8420 mg of tannic acid equivalent/g of extract  
The linear regression equation was found to be y=0.022x+0.003while the 
correlation was found to be 0.999. The amount of tannin content present in the 
methanolic extract of A.nilgiricawas found to be 757.50±3.8420mg/g 
Table 8 
S.No. 
Conc. of 
tannic 
acid in 
µg/ml 
Absorbance 
at 700nm 
Conc. 
ofmethanolic 
extract in 
µg/ml 
Absorbance at 
700nm 
Amount of 
tannin content 
in terms mg of 
tannic acid 
equivalent/g of 
extract 
1 20 0.589±0.01 20 0.343±0.0860 757.50±3.8420 
2 40 1.151±0.04    
3 60 1.710±0.09    
4 80 2.390±0.03    
5 100 3.112±0.03  Average  757.50±3.8420 
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Tannins are generally defined as naturally occurring polyphenolic compounds 
of high molecular weight to form complexes with the proteins. Tannins are important 
source of protein in animals but unfortunately the amounts of tannins that they contain 
vary widely and largely unpredictably, and their effects on animals range from 
beneficial to toxicity and death 
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THIN LAYER CHROMATOGRAPHY 
SOLVENT SYSTEM  
Ethyl acetate : methanol : water =100 : 6 : 1 
Distance travelled by solute =7.5 
Distance travelled by solvent=8.6 
Rf = Distance travelled by the solute/Distance travelled by the solvent  
=        7.5/8.6  
=  0.8720 
Rf value of scopoletin matches the sample of methanolic extract of A.nilagirica .It 
may be scopoletin 
 
 
 
Fig. 15. Thin layer chromatography of MEAN 
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Table 9 
 
 
S.No. CONC.µl AUC 
 0.01 1025794 
 0.02 1659509 
 0.03 2616277 
 0.04 3462711 
 0.05 4982576 
 0.06 6053406 
 0.07 7649223 
 0.08 8157746 
 0.09 9982937 
 0.10 10779049 
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Sample area                             1328692 
 
Sample concentration 0.016013
0.012953
 
Final concentration of 
sample 0.014483
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UV ESTIMATION OF ACTIVE PRINCIPLE FROM METHANOLIC 
EXTRACT OF Artemisia nilagirica 
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bending vibration of phenyl ring.  The band at 866 cm-1 confirms the presence of two 
adjacent hydrogen in the structure. Phenols in non-polar solvents line n-hexane  
exhibit a sharp rather weak O-H stretching absorption due to non-bonded or free OH 
groups. These non-bonded O-H stretching bands appear near 3630 cm-1 in case of 
phenols. The C-H asymmetric stretching bands generally appear for methyl group 
near 2947 cm-1  and for C-H inplane bending vibration it appears at 1346 cm-1. The 
band at 1175 cm-1 confirms the O stretching vibration in phenols.  The band at 1088 
cm-1 confims the C-O-C symmetric stretching vibration present in the compound 
structure.  
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13C NMR DETERMINATION OF ISOLATED ACTIVE PRINCIPLE 
FROM A.nilagirica 
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PROTON NMR DETERMINATION OF ISOLATED COMPOUND 
FROM A.nilagirica 
 
 
 
The  NMR  spectra  shows  the elucidation  of the sample of A.nilagirica. From  the 
Ppm values the structure of the sample can be interpreted. The observing peaks are 
interpreted and values are tabulated   
                  
 
 
 
 
 
 
Results and Discussion	
 
	 99	
 
             INTERPRETATION OF PROTON NMR Table 10 
 
S.No. Ppm(Value) Groups assigned 
1 7.265,7.257 May be due to aromatic proton 
2 5.305 May be H atom attached to alkenes 
3 2.178 May be double bonded functional 
group is present . (ketones, 
acids,aldehydes, esters and amides) 
4  1.582,1.253  May be non functional groups 
5  0.000 May be alcohol or carboxylic acid 
 
               INTERPRETATION OF 13C NMR  Table 11 
S.No. Ppm values Groups assigned 
1 193.943,192.998 C=O (in aldehydes)
2 161.703 C=O 
3 122.195 C=C 
4 114.727 C=C in alkenes 
5 98.960,95.021 C-O 
6 77.270,77.117,77.012,76.936, 
76.879,76.764,76.679,76.621,76.564 
C-O 
7 30.971 C-C 
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PHARMACOLOGICAL ACTIVITIES 
DPPH RADICAL SCAVENGING ACTIVITY 
 This assay measures by spectrophotometer the ability of antioxidants to reduce 
2,2- diphenylpicrylhydrazyl (DPPH), another radical not commonly found in 
biological systems. The IC50  of the standard ascorbic acid was16.96mg/ml and the 
IC50 of the methanolic extract of A.nilagirica was 97.633mg/ml. 
Table 12 
S.No Conc. in 
µg/ml 
% inhibition of Ascorbic acid %inhibition of  
A.nilagirica 
1 20 60.64  ± 0.314 11.23±3.815 
2 40 65.86± 0.075 14.03±4.713 
3 60 70.08±0.0513 24.95±7.793 
4 80 76.77±0.0913 
 
35.59±7.753 
5 100 82.66±0.325 54.53±2.354 
 IC50         16.96mg/ml   97.633mg/ml 
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HYDROGEN PEROXIDE METHOD 
H2O2 scavenging activity is one of the methods for the estimation of reactive 
oxygen scavenging ability in biological material. It cannot be evaluated as the total 
antioxidant activity due to the fact that antioxidants can act directly, for example by 
scavenging reactive oxygen species (O2• −, H2O2,•OH) or by inhibiting their 
generation, or indirectly by regulating endogenous antioxidant defenses. H2O2 is 
easily and sensitively measured by using peroxidase-based assay systems. Although 
hydrogen peroxide itself is not very reactive, it can sometimes cause cytotoxicity by 
giving rise to hydroxyl radicals in the cell. Thus, removing H2O2 is very important 
throughout food systems. (Nabavi et al., 2008a) The IC50 of the standard ascorbic 
acid was 19.99mg/ml and the IC50 of the methanolic extract of A.nilagirica was 
158.8mg/ml. 
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Table 13 
S.No Conc.µg/ml %inhibition of 
ascorbic acid 
%inhibition of 
A.nilagirica 
1 40 75.54±0.58 4.30±0.673 
2 80 86.05±0.47 24.52±2.38 
3 120 89.24±0.21 48.04±3.66 
4 160 95.42±0.29 55.38±0.87 
5 200 98.63±0.31 58.55±0.900 
 IC50 16.99mg/ml 158.8mg/ml 
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ANTIOXIDANT ACTIVITY USING COD LIVER OIL 
The results obtained for methanolic extract of A. nilagirica may be attributed to 
several reasons viz. the inhibition of ferry-per ferryl complex formation, scavenging 
of OH- or superoxide radical or by changing the ratio of Fe+++ to Fe ++, reducing the 
rate of conversion ferrous or ferric by chelation of the ion itself . The IC50 of the  
standard ascorbic acid 16.81mg/ml and the IC50 of the methanolic extract of 
A.nilagirica was 50.52mg/ml. 
Table 14 
S.No. Conc µg/ml % inhibition of 
Ascorbic acid 
% inhibition of 
A.nilagirica 
1 20 61.08±0.199 44.61±0.86 
2 40 65.1±0.153 47.08±0.66 
3 60 70.86±0.080 53.52±0.721 
4 80 76.55±0.31 60.13±0.755 
5 100 82.92±0.055 68.95±0.38 
 IC50 16.81mg/ml 50.52mg/ml 
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 ANTITHYROID ACTIVITY 
Thyroid hormones (T3 and T4) are involved in the regulation of numerous 
body functions including lipid and carbohydrate metabolism, oxygen consumption, 
and several physiological functions such as development, reproduction, and growth 
[117]. Alterations in their normal levels cause some biochemical and clinical 
abnormalities such as hypothyroidism and hyperthyroidism [118]. Extended exposure 
to the treatment with exogenous LT4 may alter thyroid activity by interfering with 
thyroid hormones synthesis, which provokes the disruption of thyroid axis, resulting 
in numerous abnormalities [119]. Hyperthyroidism simply defined as increases of 
serum T3 and T4 with decrease of serum TSH, a pituitary hormone that regulated 
thyroid functions [120.121]. In the present study, LT4-induced increases of serum T3 
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and T4 levels, and decreases of serum TSH concentrations were significantly and 
dose-dependently inhibited by treatment of MEAN extracts.  
 
SERUM THYROID HORMONE LEVELS IN THE LT4 AND TEST 
MATERIALS TREATED RATS  
Table 15 
GROUPS 
Thyroid stimulating 
hormone(µg/ml)TSH
Triiodothyronine 
(µg/ml) T3 
Thyroxine(µg/ml) 
T4 
Normal control 
10ml/kg 1% 
CMC 
1.80±0.20 0.50±0.17 42.30±4.15 
LT4 treated 
animals 
(Hyperthyroid 
control) 
0.62±0.15 1.82±0.21 152.40±7.40 
STD control 
PTU 10mg/kg 
1.56±0.18∆a 0.98±0.19∆a 68.90±5.60∆a 
MEAN 
150mg/kg 
1.40±0.12∆b 1.20±0.20∆b 82.50±6.15∆b 
MEAN 
250mg/kg 
1.48±0.14∆b 1.06±0.18∆b 73.40±5.80∆b 
 
Values are expressed as Mean ± SEM 
∆aValues are significantly different from normal control at P < 0.01 
∆bValues are significantly different from Toxic control at P<0.01 
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INVIVO ANTI OXIDANT ACTIVITY 
The activity has been well documented that thyroid dysfunctions increases 
LPO reactions and reactive oxygen species (ROS) [118]. LPO is an autocatalytic 
mechanism leading to oxidative destruction of cellular membranes [122]. Such 
destruction can lead to cell death and to the production of toxic and reactive aldehyde 
metabolites called free radicals, where MDA is the most important [123]. It is known 
that ROS would lead to oxidative damage of biological macromolecules, including 
lipids, proteins, and DNA [118], and oxidative stress also influenced to the body 
adipocyte results in decreases of body fat masses and related body weight decreases . 
MDA is a terminal product of LPO. So the content of MDA can be used to estimate 
the extent of LPO [118], and marked increases of liver MDA contents have been 
observed in hyperthyroid animals [, 124,125]. GSH is representative endogenous 
antioxidants; prevent tissue damage by keeping the ROS at low levels and at certain 
cellular concentrations,and accepted as protective antioxidant factors in tissues [126]. 
SOD is one of the antioxidant enzymes that contribute to enzymatic defense 
mechanisms, and catalase is an enzyme catalyzes the conversion of H2O2 to H2O 
[36]. The increase of some antioxidant enzymes activities such as SOD and catalase 
may be indicative of the failure of compensating the induced oxidative stress [127]. In 
hyperthyroidism, it is well known that marked decreases of tissue GSH contents were 
induced, represent the decreases of antioxidant defense systems [129.130]. 
Controversially, SOD and catalase activities were increase to remove over-produced 
ROS as of indication of the failure of compensating the induced oxidative stress 
[127,]. LT4-induced oxidative stresses and related organ damages were ameliorated 
by treatment of MEAN extracts in the present study like other previously tested 
antioxidants [3, 9, 14, 15], as direct evidenced that MEAN  have potent antioxidant 
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effects enough to inhibited hyperthyroidisms.. In the present study, we only focused 
on the in vivo protective effects to hyperthyroidism of crud extract itself not on the 
active compounds. Thus, these active compound searches should be proceeding in 
future. 
LIVER LIPIDPEROXIDATION AND ANTIOXIDANT DEFENSE 
SYSTEM IN THE LT4 AND TEST  MATERIALS  TREATED  
RATS Table 16 
Groups 
Lipid 
Peroxidation 
(nN/mg 
protein) 
GSH (mN/mg 
protein) 
SOD(U/mg 
protein) 
Catalase(U/mg 
protein) 
Normal control 
10 mg/kg 
1%CMC 
1.60±0.25 27.30±2.60 19.00±2.80 21.15±1.20 
LT4 treated 
animals 
(Hyperthyroid 
control) 
3.80 ± 0.45∆a 12.60 ±1.75∆a 40.15 ± 5.25∆a 39.30 ±3.10∆a 
STD control 
PTU 10mg/kg 
2.70 ± 0.68∆b 19.60 ± 2.10∆b 24.10 ±3.40∆b 26.45 ±2.45∆b 
MEAN 
150mg/kg 
2.98 ± 0.76∆b 23.15 ± 2.30∆b 31.26 ± 4.45∆b 31.30 ± 2.70∆b 
MEAN 
250mg/kg 
2.84±0.70∆b 27.72 ± 2.05∆b 26.35 ± 3.80∆b 28.50 ± 2.60∆b 
Values are expressed as Mean ± SEM 
∆a Values are significantly different from normal control at P<0.01 
∆b Values are significantly different from toxic control at P<0.01 
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SERUM GLUCOSE CONCENTRATION IN HYPERTHYROID 
RATS   Table 17 
Groups Serum glucose concentration (mg/dL) 
Normal control 10 mg/kg 1%cmc 40.19333 ± 0.597 
LT4 treated animals (Hyperthyroid 
control) 
80.30333 ± 0.490725 
STD control PTU 10mg/kg 46.19333 ± 0.166966 
MEAN 150mg/kg 54.73667 ± 0.139682 
MEAN 250mg/kg 50.26 ± 0.2381 
 
                     LT4 induced hyperthyroid rats has hyperglycemia because of stress. 
Since thyroid hormones are also gluconeogenic  as well as glycolgenolytic in nature, 
the changes in serum glucose concentrations could be the result of  methanolic  
extract of  A. nilagirica induced alterations in the status of thyroid functions in 
animals 
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SUMMARY AND  CONCLUSION 
 
This dissertation is entitled Pharmacognostic, Phytochemical,Antithyroid, 
Antioxidative and Antihyperglycemic evaluation of Artemisia 
nilagirica.C.B.clarke(Compositae) The review of literature revealed very little 
information on the pharmacognostic and pharmacological work of the leaves of 
Artemisia nilagirica.Hence it was decided to carry out the work on macroscopic and 
microscopic studies.It revealed the following characters which will play an important 
role in the authentication of crude drug and will also be useful for the detection of 
adulteration. 
a) The leaves are simple ,oppositely arrangedand lobed 
b) The microscopy of leaves shows that the midrib is thick and wide abaxial part 
&wide  adaxial part. 
c) The stomata is anomocytic with epidermal cells and the  glandulartrichomes 
are two celled. 
d) The reticulate venation are seen and rectangular to polygonal in shape. 
e) . The vascular bundles are collateral with dense, compact rows of small, xylem 
elements and thick band of compact phloem elements in the petiole part. 
f) Evaluation of powder microscopy showed two celled glandular trichomes.  
The macroscopy and microscopy features has added more weightage to the 
authenticity of the plant.The quantitative  analytical microscopy and standardisation 
parameters gives values which are constant and will be useful for quality and purity of 
the crude drug. 
           Preliminary phytochemical screening and quantitative estimation of 
phytoconstituents throws light on the type of secondary metabolites present in 
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theplant.The isolation  of the active priciple in the methanolic extract by 
coloumnchromatography.HPLC  shows the quantification of the active principle for  
determining the amount of secondary metabolites which may responsible for the 
pharmacological activity.   
 The isolated activate  principle shows the  structural elucidation by the 
spectroscopical methods UV , FTIR and NMR   
The various pharmacological activities carried out included invitro and invivo 
antioxidant activities, antithyroid and antihyperglycemic activities. The antithyroid 
activities showed that the amount of TSH, T3 and T4  present in the serum samples. 
Then the antioxidant defense system are LPO which measures antioxidative stress and 
other antioxidative  defense systems are CAT,SOD and GSH. The antihyper glycemic 
activity by estimation of serum glucose concentration . Hence the presence of  the 
secondary metabolites collaborates a wide range of biological activities such as 
antithyroid, anti oxidative and antihyper glycemicavctivity. 
In conclusion the pharmacognostic features, physicochemical constants, 
phytochemical constants, preliminary phytochemical studies, column 
chromatography, spectroscopical methods (UV, FTIR and NMR) HPLC shows that 
the quality and quantity of the secondary metabolites. It may be concluded that 
Artemisia nilagirica could be a potential source of medicine exhibiting wide range of 
biological activity.  
LT4-induced hypothyroidism and liver damages were inhibited by oral 
treatment of MEAN  150 and 300mg/kg. In addition, they also enhanced the liver 
antioxidant defense systems—they dose-dependently inhibited LT4-induced increases 
of LPO and changes on the GSH contents, SOD, and catalase activities as direct 
evidences that MEAN  have favorable ameliorating effect on the hyperthyroidisms 
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and related organ damages induced by LT4 through antioxidant effects. MEAN  
showed comparable effects on the LT4-induced rat hyperthyroidism as compared with 
PTU 10mg/kg. These effects of MEAN may help the improvement of 
hyperthyroidisms and accompanied various organ damages, but active compound 
searches should be proceeding in future. 
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